Youngevity International (YGYI) 10-Q 22 Jun 22 2020 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2020	Jun. 17, 2022
Document Information [Line Items]
Entity Central Index Key	0001569329
Entity Registrant Name	Youngevity International, Inc.
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2020
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2020
Document Transition Report	false
Entity File Number	001-38116
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	90-0890517
Entity Address, Address Line One	2400 Boswell Road
Entity Address, City or Town	Chula Vista
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	91914
City Area Code	619
Local Phone Number	934-3980
Entity Current Reporting Status	Yes
Entity Interactive Data Current	No
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		34,044,176

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Current Assets
Cash and cash equivalents	$ 1,238	$ 4,463
Accounts receivable, trade	3,043	2,902
Income tax receivable	81	81
Inventory	22,036	22,706
Prepaid expenses and other current assets	5,432	3,982
Total current assets	31,830	34,134
Property and equipment, net	25,189	23,316
Operating lease right-of-use assets	6,467	8,386
Deferred tax assets	75	75
Intangible assets, net	13,726	15,566
Goodwill	6,992	6,992
Other assets	1,279	1,222
Total assets	85,558	89,691
Current Liabilities
Accounts payable	9,405	9,069
Accrued distributor compensation	4,167	3,164
Accrued expenses	5,732	5,108
Deferred revenues	8,527	1,943
Line of credit	1,955	2,011
Other current liabilities	3,018	2,664
Operating lease liabilities, current portion	1,290	1,740
Finance lease liabilities, current portion	1,703	736
Notes payable, net of debt discounts, current portion (Note 3)	5,340	4,085
Convertible notes payable, net of debt discounts, current portion	2,927	25
Short term loans	3,923	0
Warrant derivative liability	0	1,542
Contingent acquisition debt, current portion	1,341	1,263
Total current liabilities	51,436	33,541
Operating lease liabilities, net of current portion	5,497	6,646
Finance lease liabilities, net of current portion	1,081	408
Notes payable, net of debt discounts, net of current portion	4,883	6,790
Convertible notes payable, net of debt discounts, net of current portion	0	2,675
Contingent acquisition debt, net of current portion	5,455	7,348
Other long-term liabilities	0	2,115
Total liabilities	68,744	59,523
Commitments and contingencies (Note 11)
Stockholders’ Equity
Common stock, $0.001 par value: 50,000,000 shares authorized; 32,236,994 and 30,274,601 shares issued and outstanding at September 30, 2020 and December 31, 2019, respectively	32	30
Additional paid-in capital	268,390	265,825
Accumulated deficit	(251,154)	(235,751)
Accumulated other comprehensive income (loss)	(454)	64
Total stockholders’ equity	16,814	30,168
Total Liabilities and Stockholders’ Equity	85,558	89,691
Series A Convertible Preferred Stock [Member]
Stockholders’ Equity
Preferred stock	0	0
Series B Convertible Preferred Stock [Member]
Stockholders’ Equity
Preferred stock	0	0
Series D Cumulative Redeemable Perpetual Preferred Stock [Member]
Stockholders’ Equity
Preferred stock	0	0
Notes Payable Excluding Convertible Notes Payable [Member]
Current Liabilities
Notes payable, net of debt discounts, current portion	2,108	191
Notes payable, net of debt discounts, net of current portion (Note 3)	$ 392	$ 0

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($) $ in Thousands	4 Months Ended	9 Months Ended	12 Months Ended
	Dec. 31, 2019	Sep. 30, 2020	Dec. 31, 2019
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	5,000,000	5,000,000	5,000,000
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	50,000,000	50,000,000	50,000,000
Common stock, shares issued (in shares)	30,274,601	32,236,994	30,274,601
Common stock, shares outstanding (in shares)	30,274,601	32,236,994	30,274,601
Series A Convertible Preferred Stock [Member]
Preferred stock, shares authorized (in shares)		161,135
Preferred stock, dividend rate		8%	8%
Preferred stock, shares issued (in shares)	161,135	161,135	161,135
Preferred stock, shares outstanding (in shares)	161,135	161,135	161,135
Series B Convertible Preferred Stock [Member]
Preferred stock, shares authorized (in shares)		1,052,631
Preferred stock, dividend rate		5%	5%
Preferred stock, shares issued (in shares)	129,332	0	129,332
Preferred stock, shares outstanding (in shares)	129,332	0	129,332
Series D Cumulative Redeemable Perpetual Preferred Stock [Member]
Preferred stock, par value (in dollars per share)		$ 0.001
Preferred stock, shares authorized (in shares)		650,000
Preferred stock, dividend rate	9.75%	9.75%	9.75%
Preferred stock, shares issued (in shares)	578,898	590,273	578,898
Preferred stock, shares outstanding (in shares)	578,898	590,273	578,898
Preferred stock, liquidation preference		$ 14,877

Unaudited Condensed Consolidate

Unaudited Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Revenues	$ 34,002,000	$ 33,380,000	$ 102,525,000	$ 112,789,000
Cost of revenues	14,248,000	13,642,000	42,938,000	40,522,000
Gross profit	19,754,000	19,738,000	59,587,000	72,267,000
Operating expenses
Distributor compensation	13,262,000	13,122,000	40,044,000	42,509,000
Sales and marketing	3,053,000	4,432,000	9,398,000	11,237,000
General and administrative	8,101,000	10,663,000	25,336,000	38,795,000
Total operating expenses	24,416,000	28,217,000	74,778,000	92,541,000
Operating loss	(4,662,000)	(8,479,000)	(15,191,000)	(20,274,000)
Other income (expenses), net
Interest expense, net	(658,000)	(1,109,000)	(1,917,000)	(3,678,000)
Change in fair value of warrant derivative liability	101,000	2,457,000	1,542,000	4,344,000
Loss on modification of warrants	0	(876,000)	0	(876,000)
Total other income (expenses), net	(557,000)	472,000	(375,000)	(210,000)
Loss before income taxes	(5,219,000)	(8,007,000)	(15,566,000)	(20,484,000)
Income tax benefit	(147,000)	(133,000)	(163,000)	(61,000)
Net loss	(5,072,000)	(7,874,000)	(15,403,000)	(20,423,000)
Preferred stock dividends	(362,000)	(85,000)	(1,104,000)	(127,000)
Net loss attributable to common stockholders	$ (5,434,000)	$ (7,959,000)	$ (16,507,000)	$ (20,550,000)
Net loss per share, basic (in dollars per share)	$ (0.17)	$ (0.27)	$ (0.52)	$ (0.71)
Net loss per share, diluted (Note 1) (in dollars per share)	$ (0.17)	$ (0.27)	$ (0.52)	$ (0.76)
Weighted average shares outstanding, basic (in shares)	32,233,622	30,035,182	31,479,884	28,924,305
Weighted average shares outstanding, diluted (in shares)	32,233,622	30,039,676	31,479,884	29,003,331

Unaudited Condensed Consolida_2

Unaudited Condensed Consolidated Statements of Comprehensive Loss - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Net loss	$ (5,072,000)	$ (7,874,000)	$ (15,403,000)	$ (20,423,000)
Foreign currency translation	(299,000)	9,000	(518,000)	49,000
Total other comprehensive income (loss)	(299,000)	9,000	(518,000)	49,000
Comprehensive loss	$ (5,371,000)	$ (7,865,000)	$ (15,921,000)	$ (20,374,000)

Unaudited Condensed Consolida_3

Unaudited Condensed Consolidated Statements of Stockholders' Equity - USD ($)	Share-Based Payment Arrangement, Employee [Member] Preferred Stock [Member] Series A Convertible Preferred Stock [Member]	Share-Based Payment Arrangement, Employee [Member] Preferred Stock [Member] Series B Convertible Preferred Stock [Member]	Share-Based Payment Arrangement, Employee [Member] Preferred Stock [Member] Series D Cumulative Redeemable Perpetual Preferred Stock [Member]	Share-Based Payment Arrangement, Employee [Member] Common Stock [Member]	Share-Based Payment Arrangement, Nonemployee [Member] Preferred Stock [Member] Series A Convertible Preferred Stock [Member]	Share-Based Payment Arrangement, Nonemployee [Member] Preferred Stock [Member] Series B Convertible Preferred Stock [Member]	Share-Based Payment Arrangement, Nonemployee [Member] Preferred Stock [Member] Series D Cumulative Redeemable Perpetual Preferred Stock [Member]	Share-Based Payment Arrangement, Nonemployee [Member] Common Stock [Member]	Warrants for Service [Member] Preferred Stock [Member] Series A Convertible Preferred Stock [Member]	Warrants for Service [Member] Preferred Stock [Member] Series B Convertible Preferred Stock [Member]	Warrants for Service [Member] Preferred Stock [Member] Series D Cumulative Redeemable Perpetual Preferred Stock [Member]	Warrants for Service [Member] Common Stock [Member]	Warrants for Service [Member] Additional Paid-in Capital [Member]	Warrants for Service [Member] AOCI Attributable to Parent [Member]	Warrants for Service [Member] Retained Earnings [Member]	Warrants for Service [Member]	Warrants Upon Vesting for Service [Member] Preferred Stock [Member] Series A Convertible Preferred Stock [Member]	Warrants Upon Vesting for Service [Member] Preferred Stock [Member] Series B Convertible Preferred Stock [Member]	Warrants Upon Vesting for Service [Member] Preferred Stock [Member] Series D Cumulative Redeemable Perpetual Preferred Stock [Member]	Warrants Upon Vesting for Service [Member] Common Stock [Member]	Warrants Upon Vesting for Service [Member] Additional Paid-in Capital [Member]	Warrants Upon Vesting for Service [Member] AOCI Attributable to Parent [Member]	Warrants Upon Vesting for Service [Member] Retained Earnings [Member]	Warrants Upon Vesting for Service [Member]	Underwritten Registered Public Offering [Member] Preferred Stock [Member] Series A Convertible Preferred Stock [Member]	Underwritten Registered Public Offering [Member] Preferred Stock [Member] Series B Convertible Preferred Stock [Member]	Underwritten Registered Public Offering [Member] Preferred Stock [Member] Series D Cumulative Redeemable Perpetual Preferred Stock [Member]	Underwritten Registered Public Offering [Member] Common Stock [Member]	Underwritten Registered Public Offering [Member] Additional Paid-in Capital [Member]	Underwritten Registered Public Offering [Member] AOCI Attributable to Parent [Member]	Underwritten Registered Public Offering [Member] Retained Earnings [Member]	Underwritten Registered Public Offering [Member]	Shares With Hemp Joint Venture Agreement [Member] Preferred Stock [Member] Series A Convertible Preferred Stock [Member]	Shares With Hemp Joint Venture Agreement [Member] Preferred Stock [Member] Series B Convertible Preferred Stock [Member]	Shares With Hemp Joint Venture Agreement [Member] Preferred Stock [Member] Series D Cumulative Redeemable Perpetual Preferred Stock [Member]	Shares With Hemp Joint Venture Agreement [Member] Common Stock [Member]	Shares With Hemp Joint Venture Agreement [Member] Additional Paid-in Capital [Member]	Shares With Hemp Joint Venture Agreement [Member] AOCI Attributable to Parent [Member]	Shares With Hemp Joint Venture Agreement [Member] Retained Earnings [Member]	Shares With Hemp Joint Venture Agreement [Member]	Private Placement [Member] Preferred Stock [Member] Series A Convertible Preferred Stock [Member]	Private Placement [Member] Preferred Stock [Member] Series B Convertible Preferred Stock [Member]	Private Placement [Member] Preferred Stock [Member] Series D Cumulative Redeemable Perpetual Preferred Stock [Member]	Private Placement [Member] Common Stock [Member]	Private Placement [Member] Additional Paid-in Capital [Member]	Private Placement [Member] AOCI Attributable to Parent [Member]	Private Placement [Member] Retained Earnings [Member]	Private Placement [Member]	Land [Member] Preferred Stock [Member] Series A Convertible Preferred Stock [Member]	Land [Member] Preferred Stock [Member] Series B Convertible Preferred Stock [Member]	Land [Member] Preferred Stock [Member] Series D Cumulative Redeemable Perpetual Preferred Stock [Member]	Land [Member] Common Stock [Member]	Land [Member] Additional Paid-in Capital [Member]	Land [Member] AOCI Attributable to Parent [Member]	Land [Member] Retained Earnings [Member]	Land [Member]	Trademarks [Member] Preferred Stock [Member] Series A Convertible Preferred Stock [Member]	Trademarks [Member] Preferred Stock [Member] Series B Convertible Preferred Stock [Member]	Trademarks [Member] Preferred Stock [Member] Series D Cumulative Redeemable Perpetual Preferred Stock [Member]	Trademarks [Member] Common Stock [Member]	Trademarks [Member] Additional Paid-in Capital [Member]	Trademarks [Member] AOCI Attributable to Parent [Member]	Trademarks [Member] Retained Earnings [Member]	Trademarks [Member]	Preferred Stock [Member] Series A Convertible Preferred Stock [Member]	Preferred Stock [Member] Series B Convertible Preferred Stock [Member]	Preferred Stock [Member] Series D Cumulative Redeemable Perpetual Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Total
Balance (in shares) at Dec. 31, 2018																																																																	161,135	129,437	0	25,760,708
Balance at Dec. 31, 2018																																																																	$ 0	$ 0	$ 0	$ 26,000	$ 206,757,000	$ (45,000)	$ (183,763,000)	$ 22,975,000
Net loss																																																																	0	0	0	0	0	0	(20,423,000)	(20,423,000)
Foreign currency translation adjustment																																																																	$ 0	$ 0	$ 0	$ 0	0	49,000	0	49,000
Issuance of common stock for vesting of restricted stock units (in shares)																																																																	0	0	0	1,389
Issuance of common stock for vesting of restricted stock units																																																																	$ 0	$ 0	$ 0	$ 0	0	0	0	0
Dividends on preferred stock																																																																	0	0	0	0	(127,000)	0	0	(127,000)
Stock based compensation expense																																																																	$ 0	$ 0	$ 0	$ 0	12,418,000	0	0	12,418,000
Issuance of common stock for conversion of Series B preferred stock (in shares)																																																																	0	(105)	0	210
Issuance of common stock for conversion of Series B preferred stock																																																																	$ 0	$ 0	$ 0	$ 0	0	0	0	0
Issuance of common stock for debt financing, net of issuance costs (in shares)																																																																	0	0	0	40,000
Issuance of common stock for debt financing, net of issuance costs																																																																	$ 0	$ 0	$ 0	$ 0	350,000	0	0	350,000
Stock issued, new issues (in shares)																									0	0	333,500	0													0	0	0	505,000
Stock issued, new issues																									$ 0	$ 0	$ 0	$ 0	$ 7,323,000	$ 0	$ 0	$ 7,323,000									$ 0	$ 0	$ 0	$ 0	$ 3,125,000	$ 0	$ 0	$ 3,125,000
Issuance of common stock from exercise of stock options and warrants (in shares)																																																																	0	0	0	1,164,102
Issuance of common stock from exercise of stock options and warrants																																																																	$ 0	$ 0	$ 0	$ 2,000	5,371,000	0	0	5,373,000
Issuance of common stock, related to ATM Financing (in shares)																																																																	0	0	0	17,524
Issuance of common stock, related to ATM Financing																																																																	$ 0	$ 0	$ 0	$ 0	102,000	0	0	102,000
Issuance of common stock for services (in shares)																																																																	0	0	0	250,600
Issuance of common stock for services																																																																	$ 0	$ 0	$ 0	$ 0	1,466,000	0	0	1,466,000
Warrant issued									$ 0	$ 0	$ 0	$ 0	$ 414,000	$ 0	$ 0	$ 414,000	$ 0	$ 0	$ 0	$ 0	$ 2,196,000	$ 0	$ 0	$ 2,196,000
Issuance of common stock for inducement shares (in shares)																																																																	0	0	0	64,250
Issuance of common stock for inducement shares																																																																	$ 0	$ 0	$ 0	$ 0	478,000	0	0	478,000
Issuance of common stock for convertible note financing, net of issuance costs																																																																	0	0	$ 0	$ 0	451,000	0	0	451,000
Issuance of common stock for convertible note financing, net of issuance costs (in shares)																																																																			0	77,250
Release of warrant liability upon reclassification of liability to equity																																																																	0	0	$ 0	$ 0	1,494,000	0	0	1,494,000
Issuance of common stock for true-up shares																																																																	0	0	$ 0	$ 0	281,000	0	0	281,000
Issuance of common stock for true-up shares (in shares)																																																																			0	44,599
Issuance of common stock related to advance for working capital (note receivable) net of settlement of debt																																																																	$ 0	$ 0	$ 0	$ 1,000	2,308,000	0	0	2,309,000
Issuance of common stock related to advance for working capital (note receivable) net of settlement of debt (in shares)																																																																			0	295,910
Issuance of common stock related to purchase of assets																																																	$ 0	$ 0	$ 0	$ 0	$ 1,200,000	$ 0	$ 0	$ 1,200,000	$ 0	$ 0	$ 0	$ 0	$ 750,000	$ 0	$ 0	$ 750,000
Issuance of common stock related to purchase of assets (in shares)																																																			0	153,846							0	100,000
Issuance of common stock for acquisition of Khrysos (in shares)																																																																	0	0	0	1,794,972
Issuance of common stock for acquisition of Khrysos																																																																	$ 0	$ 0	$ 0	$ 1,000	13,999,000	0	0	14,000,000
Release of warrant liability upon warrant exercises																																																																	$ 0	$ 0	$ 0	$ 0	1,077,000	0	0	1,077,000
Balance (in shares) at Sep. 30, 2019																																																																	161,135	129,332	333,500	30,270,360
Balance at Sep. 30, 2019																																																																	$ 0	$ 0	$ 0	$ 30,000	261,434,000	4,000	(204,186,000)	57,282,000
Balance (in shares) at Dec. 31, 2018																																																																	161,135	129,437	0	25,760,708
Balance at Dec. 31, 2018																																																																	$ 0	$ 0	$ 0	$ 26,000	206,757,000	(45,000)	(183,763,000)	22,975,000
Balance (in shares) at Dec. 31, 2019																																																																	161,135	129,332	578,898	30,274,601
Balance at Dec. 31, 2019																																																																	$ 0	$ 0	$ 0	$ 30,000	265,825,000	64,000	(235,751,000)	30,168,000
Balance (in shares) at Jun. 30, 2019																																																																	161,135	129,437	0	29,316,445
Balance at Jun. 30, 2019																																																																	$ 0	$ 0	$ 0	$ 29,000	247,935,000	(5,000)	(196,312,000)	51,647,000
Net loss																																																																	0	0	0	0	0	0	(7,874,000)	(7,874,000)
Foreign currency translation adjustment																																																																	$ 0	$ 0	$ 0	$ 0	0	9,000	0	9,000
Issuance of common stock for vesting of restricted stock units (in shares)																																																																	0	0	0	1,389
Issuance of common stock for vesting of restricted stock units																																																																	$ 0	$ 0	$ 0	$ 0	0	0	0	0
Dividends on preferred stock																																																																	0	0	0	0	(85,000)	0	0	(85,000)
Stock based compensation expense																																																																	$ 0	$ 0	$ 0	$ 0	661,000	0	0	661,000
Issuance of common stock for conversion of Series B preferred stock (in shares)																																																																	0	(105)	0	210
Issuance of common stock for conversion of Series B preferred stock																																																																	$ 0	$ 0	$ 0	$ 0	0	0	0	0
Stock issued, new issues (in shares)																																																																	0	0	333,500	0
Stock issued, new issues																																																																	$ 0	$ 0	$ 0	$ 0	7,323,000	0	0	7,323,000
Issuance of common stock from exercise of stock options and warrants (in shares)																																																																	0	0	0	790,942
Issuance of common stock from exercise of stock options and warrants																																																																	$ 0	$ 0	$ 0	$ 1,000	3,630,000	0	0	3,631,000
Issuance of common stock, related to ATM Financing (in shares)																																																																	0	0	0	16,524
Issuance of common stock, related to ATM Financing																																																																	$ 0	$ 0	$ 0	$ 0	96,000	0	0	96,000
Issuance of common stock for services (in shares)																																																																	0	0	0	75,600
Issuance of common stock for services																																																																	$ 0	$ 0	$ 0	$ 0	478,000	0	0	478,000
Warrant issued									$ 0	$ 0	$ 0	$ 0	$ 414,000	$ 0	$ 0	$ 414,000	$ 0	$ 0	$ 0	$ 0	$ 270,000	$ 0	$ 0	$ 270,000
Issuance of common stock for inducement shares (in shares)																																																																	0	0	0	64,250
Issuance of common stock for inducement shares																																																																	$ 0	$ 0	$ 0	$ 0	478,000	0	0	478,000
Issuance of common stock for convertible note financing, net of issuance costs																																																																	0	0	$ 0	$ 0	23,000	0	0	23,000
Issuance of common stock for convertible note financing, net of issuance costs (in shares)																																																																			0	5,000
Release of warrant liability upon reclassification of liability to equity																																																																	$ 0	$ 0	$ 0	$ 0	211,000	0	0	211,000
Balance (in shares) at Sep. 30, 2019																																																																	161,135	129,332	333,500	30,270,360
Balance at Sep. 30, 2019																																																																	$ 0	$ 0	$ 0	$ 30,000	261,434,000	4,000	(204,186,000)	57,282,000
Balance (in shares) at Dec. 31, 2019																																																																	161,135	129,332	578,898	30,274,601
Balance at Dec. 31, 2019																																																																	$ 0	$ 0	$ 0	$ 30,000	265,825,000	64,000	(235,751,000)	30,168,000
Net loss																																																																	0	0	0	0	0	0	(15,403,000)	(15,403,000)
Foreign currency translation adjustment																																																																	$ 0	$ 0	$ 0	$ 0	0	(518,000)	0	(518,000)
Issuance of common stock for vesting of restricted stock units (in shares)																																																																	0	0	0	39,750
Issuance of common stock for vesting of restricted stock units																																																																	$ 0	$ 0	$ 0	$ 0	0	0	0	0
Shares surrendered for tax obligations for restricted stock units (in shares)	0	0	0	(9,632)	0	0	0	(1,389)
Fair value of common stock issued related to advance for working capital (recorded in prepaid expenses and other current assets)																																																																	0	0	0	0	(324,000)	0	0	(324,000)
Dividends on preferred stock																																																																	$ 0	$ 0	$ 0	$ 0	(1,104,000)	0	0	(1,104,000)
Equity-based compensation for services (in shares)																																																																	0	0	0	125,000
Equity-based compensation for services																																																																	$ 0	$ 0	$ 0	$ 0	429,000	0	0	429,000
Stock based compensation expense																																																																	$ 0	$ 0	$ 0	$ 0	777,000	0	0	777,000
Issuance of common stock for conversion of Series B preferred stock (in shares)																																																																	0	(129,332)	0	258,664
Issuance of common stock for conversion of Series B preferred stock																																																																	$ 0	$ 0	$ 0	$ 1,000	0	0	0	1,000
Issuance of common stock for debt financing, net of issuance costs (in shares)																																																																	0	0	0	50,000
Issuance of common stock for debt financing, net of issuance costs																																																																	$ 0	$ 0	$ 0	$ 0	65,000	0	0	65,000
Stock issued, new issues (in shares)																									0	0	11,375	0					0	0	0	1,500,000
Stock issued, new issues																									$ 0	$ 0	$ 0	$ 0	$ 233,000	$ 0	$ 0	$ 233,000	$ 0	$ 0	$ 0	$ 1,000	$ 2,489,000	$ 0	$ 0	$ 2,490,000
Balance (in shares) at Sep. 30, 2020																																																																	161,135	0	590,273	32,236,994
Balance at Sep. 30, 2020																																																																	$ 0	$ 0	$ 0	$ 32,000	268,390,000	(454,000)	(251,154,000)	16,814,000
Balance (in shares) at Jun. 30, 2020																																																																	161,135	0	590,273	32,216,599
Balance at Jun. 30, 2020																																																																	$ 0	$ 0	$ 0	$ 32,000	268,473,000	(155,000)	(246,082,000)	22,268,000
Net loss																																																																	0	0	0	0	0	0	(5,072,000)	(5,072,000)
Foreign currency translation adjustment																																																																	$ 0	$ 0	$ 0	$ 0	0	(299,000)	0	(299,000)
Issuance of common stock for vesting of restricted stock units (in shares)																																																																	0	0	0	31,416
Issuance of common stock for vesting of restricted stock units																																																																	$ 0	$ 0	$ 0	$ 0	0	0	0	0
Shares surrendered for tax obligations for restricted stock units (in shares)	0	0	0	(9,632)	0	0	0	(1,389)
Fair value of common stock issued related to advance for working capital (recorded in prepaid expenses and other current assets)																																																																	0	0	0	0	(101,000)	0	0	(101,000)
Dividends on preferred stock																																																																	$ 0	$ 0	$ 0	$ 0	(362,000)	0	0	(362,000)
Equity-based compensation for services (in shares)																																																																	0	0	0	0
Equity-based compensation for services																																																																	$ 0	$ 0	$ 0	$ 0	128,000	0	0	128,000
Stock based compensation expense																																																																	$ 0	$ 0	$ 0	$ 0	252,000	0	0	252,000
Balance (in shares) at Sep. 30, 2020																																																																	161,135	0	590,273	32,236,994
Balance at Sep. 30, 2020																																																																	$ 0	$ 0	$ 0	$ 32,000	$ 268,390,000	$ (454,000)	$ (251,154,000)	$ 16,814,000

Unaudited Condensed Consolida_4

Unaudited Condensed Consolidated Statements of Cash Flows	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2020 USD ($)	Sep. 30, 2019 USD ($)	Sep. 30, 2020 USD ($)	Sep. 30, 2019 USD ($)	Dec. 31, 2019 USD ($)
Cash Flows from Operating Activities:
Net loss	$ (5,072,000)	$ (7,874,000)	$ (15,403,000)	$ (20,423,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization			3,808,000	4,199,000
Stock-based compensation expense			777,000	12,418,000
Equity-based compensation for services			1,132,000	3,982,000
Amortization of debt discounts and issuance costs			1,099,000	924,000
Change in fair value of warrant derivative liability			(1,542,000)	(4,344,000)
Change in fair value of contingent acquisition debt			(1,640,000)	(911,000)
Change in allowance for other receivable (Note 3)			(324,000)	0
Change in allowance for notes receivable (Note 3)			337,000	0
Change in inventory reserve			(84,000)	889,000
Changes in allowance for accounts receivable			(30,000)	0
Gain on debt extinguishment			(48,000)	0
Loss on disposal of property and equipment			101,000	0
Loss on impairment of inventory			200,000	0
Non-cash operating lease expense			1,919,000	0
Stock issuance for true-up shares			0	281,000
Loss on modification of warrants	0	876,000	0	876,000
Deferred taxes			0	73,000
Changes in operating assets and liabilities, net of effect from business combinations:
Accounts receivable			(111,000)	(5,389,000)
Inventory			554,000	(958,000)
Prepaid expenses and other current assets			337,000	(1,411,000)
Income taxes receivable			0	(233,000)
Other assets			(395,000)	0
Accounts payable			336,000	454,000
Accrued distributor compensation			1,003,000	(37,000)
Deferred revenues			6,584,000	(307,000)
Accrued expenses and other liabilities			982,000	2,155,000
Operating lease liabilities			(1,599,000)	0
Other long-term liabilities			(68,000)	0
Net Cash Used in Operating Activities			(2,075,000)	(7,762,000)
Cash Flows from Investing Activities:
Acquisitions, net of cash acquired			0	(925,000)
Purchases of property and equipment			(3,515,000)	(5,177,000)
Net Cash Used in Investing Activities			(3,515,000)	(6,102,000)
Cash Flows from Financing Activities:
Proceeds from private placement of common stock, net of offering costs			0	2,871,000
Proceeds from the exercise of stock options and warrants, net			0	5,214,000
Proceeds from at-the-market-offering transaction			0	102,000
Proceeds from the issuance of preferred stock – series D, net of offering costs			233,000	7,323,000
Proceeds from short-term debt			3,923,000	0
Payments from line of credit, net			(56,000)	(275,000)
Payments of contingent acquisition debt			(175,000)	(333,000)
Payments of finance leases			(832,000)	(1,099,000)
Payments of dividends			(1,108,000)	(46,000)
Net Cash Provided by Financing Activities			2,883,000	18,206,000
Foreign Currency Effect on Cash			(518,000)	49,000
Net decrease in cash and cash equivalents			(3,225,000)	4,391,000
Cash and Cash Equivalents, Beginning of Period			4,463,000	2,879,000	$ 2,879,000
Cash and Cash Equivalents, End of Period	1,238,000	7,270,000	1,238,000	7,270,000	$ 4,463,000
Supplemental Disclosures of Cash Flow Information
Interest			883,000	2,641,000
Income taxes			30,000	164,000
Supplemental Disclosures of Noncash Investing and Financing Activities
Change in fair value of common stock issued for in relation to advance for working capital (Note 3)			324,000	0
Fair value of warrant issued for services, vested portion (Note 10)			0	2,196,000
Issuance of common stock for the noncash exercise of warrants			0	157,000
Dividends declared but not paid at the end of period (Note 10)	$ 120,000	$ 83,000	120,000	83,000
Stock for Nica Hemp Project [Member]
Supplemental Disclosures of Noncash Investing and Financing Activities
Stock issued			2,490,000	0
Stock Issued for Promissory Note Financing [Member]
Supplemental Disclosures of Noncash Investing and Financing Activities
Stock issued			65,000	0
Stock in Connection With Acquisition [Member]
Supplemental Disclosures of Noncash Investing and Financing Activities
Stock issued			0	14,000,000
Stock Issued for Service [Member]
Supplemental Disclosures of Noncash Investing and Financing Activities
Stock issued			0	1,880,000
Stock for Property and Equipment [Member]
Supplemental Disclosures of Noncash Investing and Financing Activities
Stock issued			0	1,200,000
Stock for Purchase of Intangibles [Member]
Supplemental Disclosures of Noncash Investing and Financing Activities
Stock issued			0	750,000
Stock for Note Receivables [Member]
Supplemental Disclosures of Noncash Investing and Financing Activities
Stock issued			0	2,309,000
Property and Equipment Funded by Financing Leasing Agreement [Member]
Supplemental Disclosures of Noncash Investing and Financing Activities
Purchases of property and equipment			427,000	42,000
Property and Equipment Funded by Mortgage Agreement [Member]
Supplemental Disclosures of Noncash Investing and Financing Activities
Purchases of property and equipment			0	977,000
Notes Payable Excluding Convertible Notes Payable [Member]
Cash Flows from Financing Activities:
Payments of notes payable			(77,000)	(108,000)
Convertible Notes Payable [Member]
Cash Flows from Financing Activities:
Payments of notes payable			(25,000)	(568,000)
Promissory Notes [Member]
Cash Flows from Financing Activities:
Proceeds from issuance of promissory notes, net of offering costs			$ 1,000,000	$ 5,125,000

Note 1 - Description of Busines

Note 1 - Description of Business and Basis of Presentation	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
Business Description and Accounting Policies [Text Block]	Note 1. Description of Business Youngevity International, Inc. (the “Company”) operates in three segments: (i) the direct selling segment where products are offered through a global distribution network of preferred customers and distributors, (ii) the commercial coffee segment where products are sold directly to businesses and (iii) the commercial hemp segment where the Company manufactures proprietary systems to provide end-to-end extraction and processing of hemp feed stock into hemp oil and hemp extracts, oil extraction services, and contract manufacturing services. Information on the operations of the Company’s three ● The direct selling segment is operated through the Company’s three 2400 twelve ● Youngevity Australia Pty. Ltd., ● Youngevity NZ, Ltd., ● Youngevity Mexico S.A. de CV, ● Youngevity Russia, LLC, ● Youngevity Israel, Ltd., ● Youngevity Europe SIA (Latvia), ● Youngevity Colombia S.A.S, ● Youngevity International Singapore Pte. Ltd., ● Mialisia Canada, Inc., ● Youngevity Global LLC, Taiwan Branch, ● Youngevity Global LLC, Philippine Branch, and ● Youngevity International (Hong Kong). The Company also operate in Indonesia, Malaysia, and Japan through its sales force of independent distributors. ● The commercial coffee business is operated through the Company’s wholly-owned subsidiary, CLR Roasters LLC (“CLR”) and its wholly-owned subsidiary, Siles Plantation Family Group S.A. (“Siles”). ● The commercial hemp business is operated through the Company’s wholly-owned subsidiary, Khrysos Industries, Inc., a Delaware corporation (“KII”). KII acquired the assets of Khrysos Global Inc., a Florida corporation (“Khrysos Global”), in February 2019 In the following text, the term “the Company” refers collectively to the Company and its subsidiaries. Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim financial information. Accordingly, certain information and footnote disclosures, normally included in financial statements prepared in accordance with generally accepted accounting principles, have been condensed or omitted pursuant to such rules and regulations. Youngevity International, Inc. (the “Company”) consolidates all wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. The condensed consolidated financial statements presented as of September 30, 2020 three nine September 30, 2020 2019 not 10 December 31, 2019, June 25, 2021. not Segment Information The Company has three reportable segments: direct selling, commercial coffee, and commercial hemp. The direct selling segment develops and distributes health and wellness products through its global independent direct selling network also known as multi-level marketing. The commercial coffee segment is engaged in coffee roasting and distribution, specializing in gourmet coffee. The commercial hemp segment manufactures proprietary systems to provide end-to-end extraction and processing that allow for the conversion of hemp feed stock into hemp oil and hemp extracts. The determination that the Company has three 280, Segment Reporting. During the three September 30, 2020, three September 30, 2019, During the nine September 30, 2020, nine September 30, 2019, Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expense for each reporting period. Estimates are used in accounting for, among other things, allowances for doubtful accounts, deferred taxes and related valuation allowances, fair value of derivative liabilities, uncertain tax positions, loss contingencies, fair value of options granted under the Company’s stock-based compensation plan, fair value of assets and liabilities acquired in business combinations, finance leases, asset impairments, estimates of future cash flows used to evaluate impairments, useful lives of property, equipment and intangible assets, value of contingent acquisition debt, inventory obsolescence, and sales returns. Actual results may may Liquidity and Going Concern The accompanying consolidated financial statements have been prepared and presented on a basis assuming the Company will continue as a going concern. The Company has sustained significant net losses during the nine September 30, 2020 2019 nine September 30, 2020 2019, Management has assessed the Company’s ability to continue as a going concern and concluded that additional capital will be required during the twelve 10 no The Company has and continues to take actions to alleviate the cash used in operations. During the nine September 30 2020, not The outbreak of COVID- 19 19. 19 not may may In addition, the outbreak of the COVID- 19 not 19 The Company continues to seek and obtain equity or debt financing on terms that are acceptable to the Company. Depending on market conditions, there can be no These financial statements have been prepared on a going concern basis, which asserts the Company has the ability in the near term to continue to realize its assets and discharge its liabilities and commitments in a planned manner giving consideration to the above and expected possible outcomes. The financial statements do not 19 not may Actual results may may Cash and Cash Equivalents The Company considers only its monetary liquid assets with original maturities of three Revenue Recognition The Company recognizes revenue from product sales when the following five Revenue is recognized upon transfer of control of promised products or services to customers in an amount that reflects the consideration the Company expects to receive in exchange for those products or services. The Company enters into contracts that can include various combinations of products and services, which are generally capable of being distinct and accounted for as separate performance obligations. Revenue is recognized net of allowances for returns and any taxes collected from customers, which are subsequently remitted to governmental authorities. The transaction price for all sales is based on the price reflected in the individual customer's contract or purchase order. Variable consideration has not Independent distributors receive compensation which is recognized as distributor compensation in the Company’s consolidated statements of operations. Due to the short-term nature of the contract with the customers, the Company accrues all distributor compensation expense in the month earned and pays the compensation the following month. The Company also charges fees to become a distributor, and earn a position in the network genealogy, which are recognized as revenue in the period received. The Company’s distributors are required to pay a one no The Company has determined that most contracts will be completed in less than one one 606 10 32 18. not one one no Revenue recognition by segment is as follows: Direct Selling. Revenue is recognized when the Company satisfies its performance obligations under the contract. The Company recognizes revenue by transferring the promised products to the customer, with revenue recognized at shipping point, the point in time the customer obtains control of the products. The majority of the Company’s contracts have a single performance obligation and are short term in nature. Sales taxes in domestic and foreign jurisdictions are collected from customers and remitted to governmental authorities, all at the local level, and are accounted for on a net basis and therefore are excluded from revenues. Commercial Coffee - Roasted Coffee. Revenue is recognized when the title and risk of loss is passed to the customer under the terms of the shipping arrangement, typically, FOB shipping point. At this point the customer has a present obligation to pay, takes physical possession of the product, takes legal title to the product, bears the risks and rewards of ownership, and as such, revenue will be recognized at this point in time. Sales taxes in domestic and foreign jurisdictions are collected from customers and remitted to governmental authorities, all at the local level, and are accounted for on a net basis and therefore are excluded from revenues. Commercial Coffee - Green Coffee. Revenue is recognized when the title and risk of loss is passed to the customer under the terms of the shipping arrangement, typically, FOB shipping point. At this point the customer has a present obligation to pay, takes physical possession of the product, takes legal title to the product, bears the risks and rewards of ownership, and as such, revenue will be recognized at this point in time. Revenues where the Company sells green coffee beans that it has milled and where the Company has determined it is the agent with regard to the green coffee beans is recorded at net or recorded to reflect only the milling services provided. Sales taxes in domestic and foreign jurisdictions are collected from customers and remitted to governmental authorities, all at the local level, and are accounted for on a net basis and therefore are excluded from revenues. Commercial Hemp. Revenue is recognized when the title and risk of loss is passed to the customer under the terms of the shipping arrangement, typically, FOB shipping point. At this point the customer has a present obligation to pay, takes physical possession of the product, takes legal title to the product, bears the risks and rewards of ownership, and as such, revenue will be recognized at this point in time. Sales taxes in domestic and foreign jurisdictions are collected from customers and remitted to governmental authorities, all at the local level, and are accounted for on a net basis and therefore are excluded from revenues. Contract Balances. may Contract liabilities are reflected as deferred revenues and customer deposits in accrued expenses, deferred revenue, other current liabilities and other long-term liabilities on the Company’s consolidated balance sheets. Contract liabilities relate to payments invoiced or received in advance of completion of performance obligations and are recognized as revenue upon the fulfillment of performance obligations. The Company recognizes deferred revenue in its direct selling, commercial coffee and commercial coffee segments. In January 2020, The deferred revenue related to Heritage Maker’s product line obligation for points purchased by customers represents cash payments received that have not 2020 not The Company also records deferred revenue within its direct selling, commercial coffee and commercial hemp segments related to payments made by customers for unshipped orders. Deferred costs relate to Heritage Makers prepaid commissions are recorded in prepaid expenses and other current assets on the Company’s consolidated balance sheets and recognized in expense at the time the related revenue is recognized. Plantation Costs The Company’s commercial coffee segment includes the results of Siles, which is comprised of (i) a 500-acre coffee plantation and (ii) a dry-processing facility located on 26 acres, both of which are located in Matagalpa, Nicaragua. Siles is a wholly-owned subsidiary of CLR, and the results of CLR include the depreciation and amortization of capitalized costs, development and maintenance and harvesting costs of Siles. In accordance with GAAP, plantation maintenance and harvesting costs for commercially producing coffee farms are charged against earnings when sold. Deferred harvest costs accumulate and are capitalized throughout the year and are expensed over the remainder of the year as the coffee is sold. The difference between actual harvest costs incurred and the amount of harvest costs recognized as expense is recorded as either an increase or decrease in deferred harvest costs, which is reported as an asset and included with prepaid expenses and other current assets in the condensed consolidated balance sheets. Once the harvest is complete, the harvest costs are then recognized as the inventory value. There were no deferred costs associated with the harvest at September 30, 2020. December 31, 2019 $350,000. Stock-based Compensation The Company accounts for stock-based compensation in accordance with ASC Topic 718, Compensation Stock Compensation, The Company uses the Black-Scholes to estimate the fair value of stock options. The use of a valuation model requires the Company to make certain assumptions with respect to selected model inputs. Expected volatility is calculated based on the historical volatility of the Company’s stock price over the expected term of the option. The expected life is based on the contractual life of the option and expected employee exercise and post-vesting employment termination behavior. The risk-free interest rate is based on U.S. Treasury zero Income Taxes The Company accounts for income taxes in accordance with ASC Topic 740, "Income Taxes," not Income taxes for the interim periods are computed using the effective tax rates estimated to be applicable for the full fiscal year, as adjusted for any discrete taxable events that occur during the period. The Company files income tax returns in the U.S. on a federal basis and in many U.S. state and foreign jurisdictions. Certain tax years remain open to examination by the major taxing jurisdictions to which the Company is subject. Commitments and Contingencies The Company is from time to time, the subject of claims and suits arising out of matters related to the Company’s business. The Company is party to litigation at the present time and may not Basic and Diluted Net Loss Per Share Basic loss per share is computed by dividing net loss attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted loss per share is computed by dividing net loss attributable to common stockholders by the sum of the weighted-average number of common shares outstanding during the period and the weighted-average number of dilutive common share equivalents outstanding during the period, using the treasury stock method. Dilutive common share equivalents are comprised of stock options, restricted stock, warrants, convertible preferred stock and common stock associated with the Company's convertible notes based on the average stock price for each period using the treasury stock method. Potentially dilutive shares are excluded from the computation of diluted net loss per share when their effect is anti-dilutive. In periods where a net loss is presented, all potentially dilutive securities are anti-dilutive and are excluded from the computation of diluted net loss per share. Potentially dilutive securities for the periods ended September 30, 2020 2019 September 30, 2020 2019 (unaudited) (unaudited) Warrants 5,266,187 6,238,182 Preferred stock conversions 22,786 275,600 Principal conversions on convertible notes 309,000 312,571 Stock options 4,567,368 3,705,644 Restricted stock units 429,443 456,111 Total 10,594,784 10,988,108 The calculation of diluted loss per share requires that, to the extent the average market price of the underlying shares for the reporting period exceeds the exercise price of the warrants and the presumed exercise of such securities are dilutive to loss per share for the period, an adjustment to net loss used in the calculation is required to remove the change in fair value of the warrants, net of tax from the numerator for the period. Likewise, an adjustment to the denominator is required to reflect the related dilutive shares, if any, under the treasury stock method. During the three nine September 30, 2019, Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 (unaudited) (unaudited) (unaudited) (unaudited) Loss per Share Basic Numerator for basic loss per share $ (5,434,000 ) $ (7,959,000 ) $ (16,507,000 ) $ (20,550,000 ) Denominator for basic loss per share 32,233,622 30,035,182 31,479,884 28,924,305 Loss per common share - basic $ (0.17 ) $ (0.27 ) $ (0.52 ) $ (0.71 ) Loss per Share - Diluted Numerator for basic loss per share $ (5,434,000 ) $ (7,959,000 ) $ (16,507,000 ) $ (20,550,000 ) Adjust: Fair value of dilutive warrants outstanding - (27,000 ) - (1,529,000 ) Numerator for dilutive loss per share $ (5,434,000 ) $ (7,986,000 ) $ (16,507,000 ) $ (22,079,000 ) Denominator for basic loss per share 32,233,622 30,035,182 31,479,884 28,924,305 Plus: Incremental shares underlying “in the money” warrants outstanding - 4,494 - 79,026 Denominator for dilutive loss per share 32,233,622 30,039,676 31,479,884 29,003,331 Loss per common share - diluted $ (0.17 ) $ (0.27 ) $ (0.52 ) $ (0.76 ) Recently Issued and Adopted Accounting Pronouncements The Company does not not nine September 30, 2020, not

Note 2 - Acquisitions and Busin

Note 2 - Acquisitions and Business Combinations	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
Business Combination Disclosure [Text Block]	Note 2. During 2019, two As such, the major purpose for the business combinations was to increase revenue and profitability. The acquisitions were structured as asset purchases which resulted in the recognition of certain intangible assets. During the nine September 30, 2020, not 2019 BeneYOU On October 31, 2019, November 1, 2019, two The Company is obligated to make monthly payments based on a percentage of the BeneYOU distributor revenue derived from sales of the Company’s products and a percentage of royalty revenue derived from sales of BeneYOU products until the earlier of the date that is ten The contingent consideration’s estimated fair value at the date of acquisition was approximately $2,648,000 as determined by management using a discounted cash flow methodology. The acquisition related costs, such as legal costs and other professional fees were minimal and expensed as incurred. The purchase agreement contains customary representations, warranties and covenants of the Company, BeneYOU and the BeneYOU Representing Party. Subject to certain customary limitations the BeneYOU Representing Party have agreed to indemnify the Company and BeneYOU against certain losses related to, among other things, breaches of the BeneYOU Representing Party’s representations and warranties, certain specified liabilities and the failure to perform covenants or obligations under the purchase agreement. The Company recorded the fair value at the date of acquisition of the acquired tangible and intangible assets and liabilities as follows (in thousands): Contingent consideration $ 2,648 Aggregate purchase price $ 2,648 The following table summarizes the fair values of the assets acquired and liabilities assumed in November 2019 ( Current assets (excluding inventory) $ 408 Inventory (net of $469 441 Trademarks and trade name 343 Distributor organization 1,175 Customer relationships 44 Non-compete agreement 277 Goodwill 669 Current liabilities (709 ) Net assets acquired $ 2,648 The reported fair value of intangible assets acquired of $1,839,000 was determined through the use of a third Goodwill of $669,000 was recognized as the excess purchase price over the acquisition-date fair value of net assets acquired. Goodwill is estimated to represent the synergistic values expected to be realized from the combination of the two The pro-forma effect assuming the business combination with BeneYOU discussed above had occurred at the beginning of 2019 not not Khrysos Global, Inc. On February 12, 2019, The aggregate consideration payable for the assets of Khrysos Global and the equity of INXL and INXH of $16,000,000 is to be paid as set forth under the terms of the AEPA and allocated between Khrysos Global and Leigh Dundore in such manner as they determine at their discretion. At closing, Khrysos Global and the Khrysos Representing Party received an aggregate of 1,794,972 shares of the Company’s common stock which had a value of $14,000,000 for the purposes of the AEPA and $500,000 in cash. The fair value of the common stock calculated as part of the acquisition valuation was approximately $14,000,000. In addition, the Company agreed to pay the sellers $1,500,000 in cash towards the AEPA of which $1,000,000 was paid to Khrysos Global and the Khrysos Representing Party during 2019. not September 30, 2020 December 31, 2019, The AEPA contains customary representations, warranties and covenants of the Company, Khrysos Global and the Khrysos Representing Party. Subject to certain customary limitations Khrysos Global and the Khrysos Representing Party have agreed to indemnify the Company and KII against certain losses related to, among other things, breaches of the Khrysos Representing Party’s representations and warranties, certain specified liabilities and the failure to perform covenants or obligations under the AEPA. In conjunction with the acquisition and organization of KII, the Company retained Dwayne Dundore as President of KII. Previously agreed-upon equity compensation in the form of warrants that was to be provided as part of the closing to Dwayne Dundore by the Company were mutually terminated. Effective September 17, 2020, no The Company has estimated fair value at the date of acquisition of the acquired tangible and intangible assets and liabilities as follows (in thousands): Present value of cash consideration $ 1,894 Estimated fair value of common stock issued 14,000 Aggregate purchase price $ 15,894 The following table summarizes the estimated and as adjusted fair values of the assets acquired and liabilities assumed in February 2019 ( Current assets $ 636 Inventory 1,264 Property, plant and equipment 1,133 Trademarks and trade name 1,876 Customer-related intangible 5,629 Non-compete intangible 956 Goodwill 6,831 Current liabilities (1,904 ) Notes payable (527 ) Net assets acquired $ 15,894 The reported fair value of intangible assets acquired in the amount of $8,461,000 was determined through the use of a third 2019, 5 Goodwill of $6,831,000 was recognized as the excess purchase price over the acquisition-date fair value of net assets acquired. In connection with the Company’s annual impairment test in 2019, 5 The costs related to the acquisition are included in legal and accounting fees and were expensed as incurred. The pro-forma effect assuming the business combination with KII discussed above had occurred at the beginning of 2019 not not

Note 3 - Related Party Transact

Note 3 - Related Party Transactions	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	Note 3. Related Party Transactions Hernandez, Hernandez, Export Y Company and H&H Coffee Group Export Corp. The Company’s wholly-owned subsidiary, CLR, is associated with Hernandez, Hernandez, Export Y Company (“H&H”), a Nicaragua company, through sourcing arrangements to procure Nicaraguan grown green coffee beans. As part of the 2014 H&H is a sourcing agent that purchases raw green coffee beans from the local producers in Nicaragua and supplies CLR’s mill with unprocessed green coffee for processing. CLR does not three nine September 30, 2019, During the three nine September 30, 2020, $229,000 nine September 30, 2019. During the three September 30, 2020 2019, nine At September 30, 2020 December 31, 2019, December 31, 2020. At September 30, 2020, ● Prepaid expenses and other current assets of approximately $1,017,000 related to green coffee acquisition, ● accounts payable of $230,000 related to billings for freight and other charges by H&H, ● accrued expenses of $544,000 primarily related to mill operation costs, and ● accrued expenses offset of $994,000 related to overpaid cost of green coffee. H&H Finance Agreement In March 2020, 2020 2019 2020 2019 not 2020 2020 September 30, 2020. In March 2021, 13 H&H Export Note Receivable In December 2018, five 41 March 2019, no October 31 October 2019, March 2019 2020 2020 November 30, 2020. Management reviewed the security against the loan and the impact of the underlying COVID crisis and determined that the full amount of the note receivable including interest of approximately $5,677,000 and $5,340,000 was not September 30, 2020 December 31, 2019, Mill Construction Agreement between CLR and H&H In January 2019, For the three nine September 30, 2020, nine September 30, 2019, At September 30, 2020, September 30, 2020, 10 In January 2019, September 30, 2020 December 31, 2019, September 30, 2020 December 31, 2019, Amended Operating and Profit-Sharing Agreement between CLR and H&H In January 2019, March 2014 three nine September 30, 2020 three nine September 30, 2019 Joint Venture Agreement in Nicaragua for Hemp Processing Center between the CLR and KII and Nicaraguan partner In April July 2020, In accordance with the terms of the Hemp Joint Venture Agreements, H&H Export will contribute the 2,200 50/50 The Nicaraguan JV Partners will contribute the excavation and preparation for hemp growth of the 2,200 45,000 The U.S. Partners will contribute all the necessary extraction equipment to convert hemp to crude oil and will also provide the feminized hemp seeds for the pilot grow program, along with their expertise in the hemp business. The U.S. Partners will also provide all necessary working capital as required. In April 2020, five December 31, 2020, The U.S. Partners and H&H Export will serve as the managing partners and all business decisions will require prior consent and agreement of both parties. The net profits and net losses for each fiscal period shall be allocated twenty five seventy five 10 Other Agreements between CLR, H&H and H&H Export In January 2019, In May 2017, three December 31, 2019 May 2020. Other Related Party Transactions Richard Renton Richard Renton was a member of the board of directors until February 11, 2020 three March 31, 2020. three nine September 30, 2019, three March 31, 2020. Carl Grover (Estate of Carl Wilford Grover) Mr. Grover was the sole beneficial owner of in excess of 5% September 30, 2020 December 31, 2019. September 30, 2020 December 31, 2019, December 2018 6 In July 2019, 2014 July 2014 December 15, 2020, Paul Sallwasser Mr. Paul Sallwasser is a member of the board directors, and prior to joining the Company’s board of directors he acquired in the Company’s 2014 2017 2017 2015 2015 2017 2017 In March 2018, 2017 2017 2017 July August 2020. In August 2019, 2014 2014 2014 At September 30, 2020 2019, Daniel Mangless Daniel Mangless became a beneficial owner of in excess of 5% March 2020. In February 2019, three 10 In June 2019, second 10 In March 2020, December 2020. 6 10 In February 2021, no 5% 13 In April 2021, March 2020. 13 2400 2400 2013. 6 JJL Equipment Holding, LLC In connection with the acquisition of Khrysos Global, the Company held a deposit from JJL Equipment Holding, LLC (“JJL Equipment”) for an equipment purchase of approximately $230,000 and $233,000 on September 30, 2020 December 31, 2019, Youngevity Be the Change Foundation Youngevity Be the Change Foundation (the “Youngevity Foundation”) was formed in 2013 501 3 three September 30, 2020 2019, nine September 30, 2020 December 31, 2019, Daniel Briskie and Maida Briskie Daniel Briskie and Maida Briskie, the father and mother of the Company’s Chief Investment Officer, entered into note purchase agreements in the principal amount of $25,000 in September 2014 2014. September 2019, 2014 one December 31, 2019, September 2020. ( 7 Douglas Briskie Douglas Briskie, the brother of the Company’s Chief Investment Officer, entered into note purchase agreements in the principal amount of $50,000 in August 2014 2014. August 2019. ( 7

Note 4 - Revenue Recognition

Note 4 - Revenue Recognition	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
Revenue from Contract with Customer [Text Block]	Note 4. Revenue Recognition The following table summarizes disaggregated revenue by segment (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 (unaudited) (unaudited) (unaudited) (unaudited) Direct selling $ 31,319 $ 30,256 $ 92,750 $ 95,800 Processed green coffee 254 (22 ) 773 1,046 Milling and processing services 211 29 535 6,416 Roasted coffee and other 2,017 2,933 7,467 9,002 Commercial coffee 2,482 2,940 8,775 16,464 Commercial hemp 201 184 1,000 525 Total revenue $ 34,002 $ 33,380 $ 102,525 $ 112,789 Contract Balances As of September 30, 2020 December 31, 2019, September 30, 2020 December 31, 2019, 2020 September 30, 2020. September 30, 2020, December 31, 2019, December 31, 2019. not September 30, 2020. Deferred revenues in the commercial coffee segment related to customer deposits were $4,305,000 at September 30, 2020. not December 31, 2019. Deferred revenues in the commercial hemp segment related to customer deposits were $627,000 on September 30, 2020. not December 31, 2019. The following table summarizes the classification of deferred revenues balances on the balance sheets (in thousands): September 30, 2020 December 31, 2019 (unaudited) Accrued expenses $ 627 $ - Deferred revenue 8,527 1,943 Other current liabilities 1,800 1,626 Deferred revenue, total $ 10,954 $ 3,569

Note 5 - Selected Consolidated

Note 5 - Selected Consolidated Balance Sheet Information	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
Supplemental Balance Sheet Disclosures [Text Block]	Note 5. Selected Consolidated Balance Sheet Information Accounts Receivable, net Net accounts receivable consists of the following (in thousands): September 30, 2020 December 31, 2019 (unaudited) Accounts receivable $ 11,253 $ 11,142 Allowance for doubtful accounts (8,210 ) (8,240 ) Accounts receivable, net $ 3,043 $ 2,902 On September 30, 2020 December 31, 2019, December 31, 2020. Inventory, net Inventories consist of the following (in thousands): September 30, 2020 December 31, 2019 (unaudited) Finished goods $ 12,448 $ 14,890 Raw materials 13,382 11,694 Total inventory 25,830 26,584 Reserve for excess and obsolete (3,794 ) (3,878 ) Inventory, net $ 22,036 $ 22,706 Property and Equipment, net Property and equipment consist of the following (in thousands): September 30, 2020 December 31, 2019 (unaudited) Buildings $ 4,117 $ 4,789 Leasehold improvements 3,148 2,948 Land 2,544 3,307 Land improvements 606 606 Producing coffee trees 553 553 Manufacturing equipment 10,464 9,568 Furniture and other equipment 2,062 2,050 Computer software 1,442 1,420 Computer equipment 2,714 2,648 Vehicles 326 326 Assets held for sale (1) 1,496 - Construction in process 9,133 6,562 Total property and equipment, gross 38,605 34,777 Accumulated depreciation (13,416 ) (11,461 ) Total property and equipment, net $ 25,189 $ 23,316 ( 1 Assets held for sale at September 30, 2020 13 Depreciation expense totaled approximately $635,000 and $617,000 for the three September 30, 2020 2019, nine Operating and Financing Leases The Company’s operating and financing lease assets and liabilities recognized within its consolidated balance sheets were classified as follows (in thousands): September 30, 2020 December 31, 2019 (unaudited) Assets Operating lease right-of-use assets $ 6,467 $ 8,386 Finance lease right-of-use assets (1) 882 1,052 Total leased assets 7,349 $ 9,438 Liabilities Operating lease liabilities, current portion $ 1,290 $ 1,740 Finance lease liabilities, current portion 1,703 736 Total leased liabilities, current portion 2,993 2,476 Operating lease liabilities, net of current portion 5,497 6,646 Finance lease liabilities, net of current portion 1,081 408 Total lease liabilities $ 9,571 $ 9,530 ( 1 Finance lease right-of-use assets are recorded within property and equipment, net of accumulated amortization of approximately $2,070,000 and $1,367,000 at September 30, 2020 December 31, 2019, In August 2020, 24 10 The weighted-average remaining lease term and weighted-average discount rate used to calculate the present value of lease liabilities are as follows: September 30, 2020 December 31, 2019 (unaudited) Weighted-average remaining lease term (in years) Operating leases 6.7 6.8 Finance leases 1.7 1.6 Weighted-average discount rate Operating leases 5.41 % 5.47 % Finance leases 17.63 % 4.57 % Operating and finance lease costs were as follows (in thousands): Three Months Ended Nine Months Ended September 30, September 30, 2020 2019 2020 2019 (unaudited) (unaudited) (unaudited) (unaudited) Operating lease cost (1) $ 495 $ 420 $ 1,591 $ 962 Finance lease cost: Amortization of leased assets (2) 311 84 703 274 Interest on lease liabilities (3) 18 30 66 101 Total operating and finance lease cost $ 824 $ 534 $ 2,360 $ 1,337 ( 1 Operating lease costs are classified within selling and marketing and general and administrative expenses. ( 2 Amortization of leased assets are classified as a component of depreciation and amortization. ( 3 Interest on lease liabilities are classified within interest expense, net. Intangible Assets Intangible assets consist of the following (in thousands): September 30, 2020 (unaudited) December 31, 2019 Cost Accumulated Amortization Net Cost Accumulated Amortization Net Distributor organizations $ 15,735 $ 11,090 $ 4,645 $ 15,735 $ 10,418 $ 5,317 Trademarks and trade names 8,430 3,070 5,360 8,430 2,539 5,891 Customer relationships 10,442 6,934 3,508 10,442 6,413 4,029 Internally developed software 720 720 - 720 657 63 Non-compete agreement 277 64 213 277 11 266 Intangible assets $ 35,604 $ 21,878 $ 13,726 $ 35,604 $ 20,038 $ 15,566 Amortization expense related to intangible assets was approximately $600,000 and $1,249,000 for the three September 30, 2020 2019, nine September 30, 2020 2019, At September 30, 2020 December 31, 2019, Goodwill Goodwill by segment consists of the following (in thousands): September 30, 2020 December 31, 2019 (unaudited) Direct selling $ 3,678 $ 3,678 Commercial coffee 3,314 3,314 Commercial hemp - - Total goodwill $ 6,992 $ 6,992

Note 6 - Notes Payable and Othe

Note 6 - Notes Payable and Other Debt	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
Debt Disclosure [Text Block]	Note 6. Notes Payable and Other Debt Credit Note In December 2018, 2014. September 30, 2020 December 31, 2019, The Credit Note accrues interest at a rate of 8.00% per annum and is paid quarterly. The Credit Note contains customary events of default including the Company or Siles failure to pay its obligations, commencing bankruptcy or liquidation proceedings, and breach of representations and warranties. Upon the occurrence of an event of default, the unpaid balance of the principal amount of the Credit Note together with all accrued but unpaid interest thereon, may may four four In connection with the Credit Note, the Company also entered into an advisory agreement with a third not four The Company recorded debt discounts of approximately $1,469,000 related to the fair value of warrants issued in the transaction and $175,000 of transaction issuance costs both of which are amortized to interest expense over the life of the Credit Note. The Company recorded amortization of approximately $245,000 and $182,000 related to the debt discount and issuance cost during the three September 30, 2020 2019, nine September 30, 2020 2019, September 30, 2020 December 31, 2019, In December 2020, not 10 no 2019 In March 2019, two “2019 two 2019 March 18, 2021. 2019 September 30, 2020 December 31, 2019, 2019 In conjunction with the 2019 five 10 The Company recorded debt discounts of approximately $212,000 related to transaction issuance costs and $139,000 related to the fair value of warrants issued in the transaction both of which are amortized to interest expense over the life of the 2019 three September 30, 2020 2019, nine September 30, 2020 2019, September 30, 2020 December 31, 2019, In February 2021, 2019 13 Mangless Note In March 2020, December 2020, December 2020, The Mangless Note provided the Company with an option to prepay at any time without permission or penalty. The Mangless Note is secured pursuant to the terms of a pledge and security agreement, entered into by the Company and CLR with Mr. Mangless, whereby the Mangless Note is secured by a first In addition, the Company issued 50,000 shares of common stock in connection with Mangless Note. (See Note 10 The Company recognized debt discounts of approximately $65,000 resulting from the allocated portion of offering proceeds to the separable common stock issuance. The debt discount was amortized to interest expense over the term of the Mangless Note. The Company recorded amortization of approximately $16,000 and $34,000 related to the debt discount during the three nine September 30, 2020, September 30, 2020, In April 2021, March 2020. 13 2400 In connection with the acquisition of 2400 2013, first September 30, 2020 December 31, 2019, September 30, 2020 December 31, 2019, The Company’s corporate office’s mortgage qualified for the mortgage payment program for a period of six Khrysos Mortgage Notes In conjunction with the Company’s acquisition of Khrysos Global, the Company assumed an interest only mortgage for properties located in Mascotte, Florida in the amount of $350,000 and interest paid monthly at a rate of 8.00% per annum. In September 2021, one September 2022 In addition, the Company assumed a mortgage of approximately $177,000 for properties located in Clermont, Florida with all unpaid principal due in June 2023 At September 30, 2020 December 31, 2019, In February 2019, February 2024 September 30, 2020 December 31, 2019, In February 2021, not 13 M2C In March 2007, M2C 2007, September 30, 2020 December 31, 2019, Small Business Administration Paycheck Protection Program Loans In April 2020, three 19 July 2020, Under the SBA loans, the Company’s direct selling segment qualified for mortgage assistance, whereby the Company’s corporate office’s mortgage had been paid directly from the SBA lenders. The Company qualified for the mortgage payment program for a period of six three nine September 30, 2020, In November 2020, April 2020 13 In April 2021, second 13 In June 2021, 2020. 13 Other Notes The Company’s other notes relate to loans for commercial vans at CLR in the amount of $56,000 and $71,000 at September 30, 2020 December 31, 2019, 2023. Line of Credit The Company’s loan and security agreement with Crestmark Bank (“Crestmark”) provides for a line of credit related to accounts receivables resulting from sales of certain products that includes borrowings to be advanced against acceptable eligible inventory related to CLR. Under the loan and security agreement the maximum overall borrowing limit on the line of credit is $6,250,000. The line of credit may not The agreement contains certain financial and nonfinancial covenants with which the Company must comply to maintain its borrowing availability and avoid penalties. At the filing date of this Quarterly Report on Form 10 not In January 2022, second February 2022, April 2022, 13 The outstanding principal balance of the line of credit bears interest based upon a 360 September 30, 2020 December 31, 2019, may not November 2017 June 30, 2022, April 2022. The Company and Stephan Wallach entered into a corporate guaranty and personal guaranty, respectively, with Crestmark guaranteeing payments in the event that the Company’s commercial coffee segment CLR were to default. In addition, David Briskie, the Company’s President and Chief Financial Officer, personally entered into a guaranty of validity representing the Company’s financial statements so long as the indebtedness is owed to Crestmark, maintaining certain covenants and guarantees. The Company’s outstanding line of credit liability related to the Crestmark Loan was approximately $1,955,000 and $2,011,000 at September 30, 2020 December 31, 2019,

Note 7 - Convertible Notes Paya

Note 7 - Convertible Notes Payable	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
Debt Disclosure [Text Block]	Note 6. Notes Payable and Other Debt Credit Note In December 2018, 2014. September 30, 2020 December 31, 2019, The Credit Note accrues interest at a rate of 8.00% per annum and is paid quarterly. The Credit Note contains customary events of default including the Company or Siles failure to pay its obligations, commencing bankruptcy or liquidation proceedings, and breach of representations and warranties. Upon the occurrence of an event of default, the unpaid balance of the principal amount of the Credit Note together with all accrued but unpaid interest thereon, may may four four In connection with the Credit Note, the Company also entered into an advisory agreement with a third not four The Company recorded debt discounts of approximately $1,469,000 related to the fair value of warrants issued in the transaction and $175,000 of transaction issuance costs both of which are amortized to interest expense over the life of the Credit Note. The Company recorded amortization of approximately $245,000 and $182,000 related to the debt discount and issuance cost during the three September 30, 2020 2019, nine September 30, 2020 2019, September 30, 2020 December 31, 2019, In December 2020, not 10 no 2019 In March 2019, two “2019 two 2019 March 18, 2021. 2019 September 30, 2020 December 31, 2019, 2019 In conjunction with the 2019 five 10 The Company recorded debt discounts of approximately $212,000 related to transaction issuance costs and $139,000 related to the fair value of warrants issued in the transaction both of which are amortized to interest expense over the life of the 2019 three September 30, 2020 2019, nine September 30, 2020 2019, September 30, 2020 December 31, 2019, In February 2021, 2019 13 Mangless Note In March 2020, December 2020, December 2020, The Mangless Note provided the Company with an option to prepay at any time without permission or penalty. The Mangless Note is secured pursuant to the terms of a pledge and security agreement, entered into by the Company and CLR with Mr. Mangless, whereby the Mangless Note is secured by a first In addition, the Company issued 50,000 shares of common stock in connection with Mangless Note. (See Note 10 The Company recognized debt discounts of approximately $65,000 resulting from the allocated portion of offering proceeds to the separable common stock issuance. The debt discount was amortized to interest expense over the term of the Mangless Note. The Company recorded amortization of approximately $16,000 and $34,000 related to the debt discount during the three nine September 30, 2020, September 30, 2020, In April 2021, March 2020. 13 2400 In connection with the acquisition of 2400 2013, first September 30, 2020 December 31, 2019, September 30, 2020 December 31, 2019, The Company’s corporate office’s mortgage qualified for the mortgage payment program for a period of six Khrysos Mortgage Notes In conjunction with the Company’s acquisition of Khrysos Global, the Company assumed an interest only mortgage for properties located in Mascotte, Florida in the amount of $350,000 and interest paid monthly at a rate of 8.00% per annum. In September 2021, one September 2022 In addition, the Company assumed a mortgage of approximately $177,000 for properties located in Clermont, Florida with all unpaid principal due in June 2023 At September 30, 2020 December 31, 2019, In February 2019, February 2024 September 30, 2020 December 31, 2019, In February 2021, not 13 M2C In March 2007, M2C 2007, September 30, 2020 December 31, 2019, Small Business Administration Paycheck Protection Program Loans In April 2020, three 19 July 2020, Under the SBA loans, the Company’s direct selling segment qualified for mortgage assistance, whereby the Company’s corporate office’s mortgage had been paid directly from the SBA lenders. The Company qualified for the mortgage payment program for a period of six three nine September 30, 2020, In November 2020, April 2020 13 In April 2021, second 13 In June 2021, 2020. 13 Other Notes The Company’s other notes relate to loans for commercial vans at CLR in the amount of $56,000 and $71,000 at September 30, 2020 December 31, 2019, 2023. Line of Credit The Company’s loan and security agreement with Crestmark Bank (“Crestmark”) provides for a line of credit related to accounts receivables resulting from sales of certain products that includes borrowings to be advanced against acceptable eligible inventory related to CLR. Under the loan and security agreement the maximum overall borrowing limit on the line of credit is $6,250,000. The line of credit may not The agreement contains certain financial and nonfinancial covenants with which the Company must comply to maintain its borrowing availability and avoid penalties. At the filing date of this Quarterly Report on Form 10 not In January 2022, second February 2022, April 2022, 13 The outstanding principal balance of the line of credit bears interest based upon a 360 September 30, 2020 December 31, 2019, may not November 2017 June 30, 2022, April 2022. The Company and Stephan Wallach entered into a corporate guaranty and personal guaranty, respectively, with Crestmark guaranteeing payments in the event that the Company’s commercial coffee segment CLR were to default. In addition, David Briskie, the Company’s President and Chief Financial Officer, personally entered into a guaranty of validity representing the Company’s financial statements so long as the indebtedness is owed to Crestmark, maintaining certain covenants and guarantees. The Company’s outstanding line of credit liability related to the Crestmark Loan was approximately $1,955,000 and $2,011,000 at September 30, 2020 December 31, 2019,
Convertible Notes Payable [Member]
Notes to Financial Statements
Debt Disclosure [Text Block]	Note 7. Total convertible notes payable, net of debt discount outstanding consisted of the amount set forth in the following table (in thousands) September 30, 2020 December 31, 2019 (unaudited) 6.00% $ 3,090 $ 3,090 Debt discounts (163 ) (415 ) Carrying value of 2019 PIPE Notes 2,927 2,675 8.00% – 25 Debt discounts – – Carrying value of 2014 PIPE Notes – 25 Total carrying value of convertible notes payable $ 2,927 $ 2,700 Unamortized debt discounts and issuance costs are included with convertible notes payable, net of debt discount on the consolidated balance sheets. 2019 Between February July 2019, five 2019 “2019 $100,000 10 The Company entered into subscription agreements with thirty-one 2019 2019 24 180th 2019 2019 September 30, 2020 December 31, 2019, 2019 Upon issuance of the 2019 2019 During the nine September 30, 2020 2019, September 30, 2020 December 31, 2019, In February March 2021, 2019 one 10 13 2014 Between July September 2014, “2014 “2014 “2014 seven five 2014 2014 In September 2019, one 2014 one September 30, 2020, 2014 In 2014, 2014 nine September 30, 2019. December 31, 2019, 2014 In 2014, 2014 2014 nine September 30, 2019. December 31, 2019, 2014

Note 8 - Derivative Liability

Note 8 - Derivative Liability	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
Derivative Instruments and Hedging Activities Disclosure [Text Block]	Note 8. Derivative Liability Warrants At, December 31, 2019, September 30, 2020. Increases or decreases in the fair value of the derivative liability are included as a component of total other expense in the accompanying consolidated statements of operations for the respective period. The changes to the derivative liability for warrants resulted in a decrease of $101,000 and $2,457,000 for the three September 30, 2020 2019, nine September 30, 2020 2019, The estimated fair value of the warrants was computed using the Monte Carlo option pricing model with the following assumptions: December 31, 2019 Stock price volatility 64.10 % Risk-free interest rates 1.59% – 1.60 % Annual dividend yield – Expected life (in years) 0.6 – 1.0 In addition, management assessed the probabilities of future financing assumptions in the valuation models.

Note 9 - Fair Value of Financia

Note 9 - Fair Value of Financial Instruments	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
Fair Value Disclosures [Text Block]	Note 9. Fair Value of Financial Instruments The following table details the fair value measurement within the fair value hierarchy of the Company’s financial instruments, which includes the Level 3 Fair Value at September 30, 2020 (unaudited) Total Level 1 Level 2 Level 3 Liabilities: Contingent acquisition debt, current portion $ 1,341 $ - $ - $ 1,341 Contingent acquisition debt, less current portion 5,455 - - 5,455 Warrant derivative liability - - - - Total derivative liabilities $ 6,796 $ - $ - $ 6,796 Fair Value at December 31, 2019 Total Level 1 Level 2 Level 3 Liabilities: Contingent acquisition debt, current portion $ 1,263 $ - $ - $ 1,263 Contingent acquisition debt, less current portion 7,348 - - 7,348 Warrant derivative liability 1,542 - - 1,542 Total derivative liabilities $ 10,153 $ - $ - $ 10,153 The following table reflects the activity for the Company’s warrant derivative liability associated with the Company’s private placements measured at fair value using Level 3 Balance at December 31, 2019 $ 1,542 Adjustments to estimated fair value (1,542 ) Balance at September 30, 2020 (unaudited) $ - The following table reflects the activity for the Company’s contingent acquisition liabilities measured at fair value using Level 3 Balance at December 31, 2019 $ 8,611 Liabilities settled (175 ) Adjustments to liabilities included in earnings (1,640 ) Balance at September 30, 2020 (unaudited) $ 6,796 The weighted-average discount rate used to determine the fair value of contingent acquisition debt was 18.50% and 18.42% at September 30, 2020 December 31, 2019,

Note 10 - Stockholders' Equity

Note 10 - Stockholders' Equity	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
Stockholders' Equity Note Disclosure [Text Block]	Note 10. Stockholders Equity The Company’s Certificate of Incorporation, as amended, authorizes the issuance of two At September 30, 2020, The Company’s common stock is traded on the OTC Pink Market operated by OTC Markets under the symbol “YGYI”. From June 2017 November 2020, June 2013 June 2017, The Company’s 9.75% Series D Cumulative Redeemable Perpetual Preferred Stock, $0.001 par value is traded on OTC Pink market operated by OTC Markets Group under the symbol “YGYIP”. Shelf Registration In May 2018, 3 3 September 30, 2020. Common Stock At September 30, 2020 December 31, 2019 March 2020 In March 2020, one March 2020 $1,000,000 March 2020, In April 2021, March 2020. 13 2019 In June 2019, In February 2019, three three February 2022 2019 In March 2019, 2019 2019 five $1,000,000 2019 2019 2019 In February 2021, 2019 13 2019 Between February July 2019, five 2019 January 2019 2019 $100,000 2019 In February March 2021, 2019 one 2019 10 13 At-the-Market Equity Offering Program In January 2019, may not December 31, 2019, not 3 3 2018 Between August 2018 October 2018, 2018 nine three December 31, 2019, 2018 2018 September 30, 2020 December 31, 2019. The Company adopted ASU No. 2017 11 January 1, 2019 2018 no 2018 2014 Debt Exchange In October 2018, 2014 July 2019, four December 2018. September 30, 2020 December 31, 2019. A FINRA broker dealer acted as the Company’s advisor in connection with the debt exchange. Upon the closing of the debt exchange, the Company subsequently received shareholder approval to issue the broker dealer 30,000 shares of common stock, a four four September 30, 2020 December 31, 2019. Preferred Stock Series A Preferred Stock The Company had 161,135 shares of Series A preferred stock outstanding at both September 30, 2020 December 31, 2019 The holders of the Series A preferred stock are entitled to receive a cumulative dividend at a rate of 8.00% per year, payable annually either in cash or shares of the Company's common stock at the Company's election. Each share of Series A preferred stock is convertible into common stock at a conversion rate of one tenth no Series B Preferred Stock In March 2018, two In connection with the Series B offering, the Company issued the placement agent 38,117 warrants as compensation, exercisable at $5.70 per share and expire in February 2023. September 30, 2020 December 31, 2019, The Company had 129,332 shares of Series B preferred stock outstanding at December 31, 2019. March 2020, two During the year ended December 31, 2019, Pursuant to the certificate of designation, the Company paid cumulative dividends on the Series B preferred stock from the date of original issue at a rate of 5.0% per annum payable quarterly in arrears on or about the last day of March, June, September December March 2020. At December 31, 2019, nine September 30, 2020 2019 March 31, 2020. no Series C Preferred Stock In connection with the Series C offering in 2018, December 31, 2019, December 31, 2019, December 2020. Series D Preferred Stock In September December 2019, two December 31, 2019, 45 December 17, 2019. In January 2020, The Series D preferred stock was approved for listing on the Nasdaq Capital Market under the symbol “YGYIP,” and trading the Series D preferred stock on Nasdaq commenced in September 2019. At September 30, 2020, September 30, 2020, The Series D preferred stock does not not first fifteenth At September 30, 2020 December 31, 2019, nine September 30, 2020, At September 30, 2020 December 31, 2019, Upon liquidation, dissolution or winding up of the Company, each holder of Series D preferred stock would be entitled to receive a distribution, to be paid in an amount equal to $25.00 per share held by the holders of Series D preferred stock, plus all accrued and unpaid dividends in preference to any distribution or payments made or any asset distributed to the holders of common stock, the Series A preferred stock, the Series B preferred stock, the Series C preferred stock or any other class or series of stock ranking junior to the Series D preferred stock. The Series D preferred stock is not September 23, 2022, may, not may, 120 first not no Advisory Agreements The Company records the fair value of common stock issued in conjunction with advisory service agreements based on the closing stock price of the Company’s common stock on the measurement date. The stock issuance expense associated with the amortization of advisory fees was recorded as stock issuance expense and was included in general and administrative expense on the Company’s consolidated statements of operations. Capital Market Solutions, LLC In July 2018, 18 August 2018 24 December 31, 2021. In January 2019, four January 2020 January 2021. During both the nine September 30, 2020 2019, nine September 30, 2019, nine September 30, 2020 2019, Corinthian Partners, LLC In August 2019, 2018 2019. Greentree Financial Group, Inc. In March 2018, 21 nine September 30, 2019, December 2019. I-Bankers Securities Incorporated In April 2019, twelve March 2020 nine September 30, 2020 2019, In addition, the Company agreed to pay in cash a base fee for debt arrangements and equity offerings in conjunction with any transactions I-Bankers closes with the Company in accordance with the agreement. The Company did not September 30, 2020. Ignition Capital, LLC In April 2018, 21 nine September 30, 2019, In March 2019, one three 2019. Ivan Gandrud Chevrolet, Inc. In March 2020, nine September 30, 2020, IGC is 100% owned by Daniel Mangless, who was the beneficial owner of in excess of 5% September 30, 2020. The Benchmark Company, LLC In August 2019, 2019. Warrants At September 30, 2020 December 31, 2019, September 30, 2020, March 2025 At December 31, 2019, September 30, 2020. The Company uses a combination of option-pricing models to estimate the fair value of the warrants including the Monte Carlo, Lattice and Black-Scholes. A summary of the warrant activity is presented in the following table: Number of Warrants Outstanding at December 31, 2019 6,238,182 Issued 250,000 Expired / cancelled (1,221,995 ) Exercised - Outstanding at September 30, 2020 (unaudited) 5,266,187 Warrant Modification loss on modification of warrants In July 2019, 2014 2014 December 15, 2020 2014 In July 2019 one “July 2014 2014 2014 July 2014 2014 July 31, 2019 July 2014 2014 2014 2014 In August 2019, one “August 2014 2014 2014 2014 2014 The Company also agreed to amend a warrant issued to Brian Frank (the “Placement Agent”) in September 2014, September 10, 2019, September 2014, September 10, 2019 ( December 15, 2020 In August 2019, one The Company considered the guidance of ASC 470 20 40, 505 50, 718 20 35, The Company concluded that the inducement of shares and the change in the terms of the warrants were considered modification of the warrant terms. The liability classified warrants were measured before and after the modification with changes in the fair value recorded to earnings. The fair value of the inducement shares was recorded as a loss on modification of warrants and a credit to additional paid in capital and common stock. Some of the equity-classified warrants were modified by issuing common shares, not These modifications result in the recognition of incremental fair value. Incremental fair value is equal to the difference between the fair value of the modified warrant and the fair value of the original warrant immediately before it was modified. Based on the above guidance, the incremental fair value of the warrants is recognized immediately, as a non-operating expense, as the warrants are not The fair value of the Placement Agent Warrants was estimated on July 29, 2019 ( August 20, 2019. The Company recorded a loss on modification of warrants expense for the three nine September 30, 2019, The Company concluded that the 2014 Stock-based Compensation Stock-based compensation expense related to stock options and restricted stock units included in the consolidated statements of operations was charged as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, (unaudited) (unaudited) (unaudited) (unaudited) 2020 2019 2020 2019 Cost of revenues $ 5 $ 6 $ 16 $ 89 Sales and marketing 31 33 92 563 General and administrative 216 622 669 11,766 Total stock-based compensation $ 252 $ 661 $ 777 $ 12,418 Stock Options A summary of the Plan stock option activity for the nine September 30, 2020 Number of Shares Weighted Average Exercise Price Weighted Average Remaining Contract Life (years) Aggregate Intrinsic Value (in thousands) Outstanding December 31, 2019 4,637,642 $ 5.63 7.8 $ - Granted - - Canceled / expired (70,274 ) 4,88 Exercised - - - Outstanding September 30, 2020 (unaudited) 4,567,368 $ 5.64 7.1 $ - Exercisable September 30, 2020 (unaudited) 4,219,877 $ 5.71 7.1 $ - The weighted-average fair value per share of the granted stock options for the nine September 30, 2019 nine September 30, 2020. At September 30, 2020, 2012 Restricted Stock Units In August 2019, three first one 2019, nine September 30, 2020, December 31, 2020. December 31, 2020. In August 2017, sixth third fourth fifth sixth nine September 30, 2020, August 2017 The Company adopted ASU 2018 07 January 1, 2019 December 31, 2018, 2018 07. A summary of restricted stock unit activity is presented in the following table: Number of Shares Balance at December 31, 2019 451,944 Issued - Canceled (10,000 ) Vested (52,251 ) Balance at September 30, 2020 (unaudited) 389,693 At September 30, 2020,

Note 11 - Commitments and Conti

Note 11 - Commitments and Contingencies	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	Note 11. Credit Risk The Company maintains cash balances at various financial institutions primarily located in the U.S. Accounts held at the U.S. institutions are secured, up to certain limits, by the Federal Deposit Insurance Corporation. At times, balances may not not Litigation The Company is party to litigation at the present time and may not may September 30, 2020 December 31, 2019, no not Vendor Concentration For the three September 30, 2020, 10% nine September 30, 2020, 10% For the three September 30, 2019, 10% nine September 30, 2019, 10% For the three September 30, 2020, 10% nine September 30, 2020, 10% For the three September 30, 2019, 10% nine September 30, 2019, 10% For the three September 30, 2020, 10% nine September 30, 2020, 10% For the three September 30, 2019, 10% nine September 30, 2019, Customer Concentration For the three September 30, 2020, 10% nine September 30, 2020, 10% For the three September 30, 2019, 10% nine September 30, 2019, At September 30, 2020 December 31, 2019, December 31, 2020. The Company has purchase obligations related to minimum future purchase commitments for green coffee to be used in the Company’s commercial coffee segment. Each individual contract requires the Company to purchase and take delivery of certain quantities at agreed upon prices and delivery dates. The contracts have minimum future purchase commitments of approximately $1,507,000 at September 30, 2020. not For the three September 30, 2020, nine September 30, 2020, For the three September 30, 2019, 10% nine September 30, 2019, 10%

Note 12 - Segment and Geographi

Note 12 - Segment and Geographical Information	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
Segment Reporting Disclosure [Text Block]	Note 12. Segment and Geographical Information The Company operates in three segments: the direct selling segment where products are offered through a global distribution network of preferred customers and distributors, the commercial coffee segment where roasted and green coffee bean products are sold directly to businesses, and the commercial hemp segment manufactures proprietary systems to provide end-to-end extraction and processing that allow for the conversion of hemp feed stock into hemp oil and hemp extracts. The Company’s segments reflect the manner in which the business is managed and how the Company allocates resources and assesses performance. The Company’s chief operating decision maker is the Chief Executive Officer. The Company’s chief operating decision maker evaluates segment performance primarily based on revenue and segment operating income (loss). The principal measures and factors the Company considered in determining the number of reportable segments were revenue, gross margin percentage, sales channel, customer type and competitive risks. The accounting policies of the segments are consistent with those described in the summary of significant accounting policies. Segment revenue excludes intercompany revenue eliminated in the consolidation. The following tables present selected financial information for each segment (in thousands): Three Months Ended Nine Months Ended September 30, September 30, 2020 2019 2020 2019 (unaudited) (unaudited) (unaudited) (unaudited) Revenues Direct selling $ 31,319 $ 30,256 $ 92,750 $ 95,800 Commercial coffee 2,482 2,940 8,775 16,464 Commercial hemp 201 184 1,000 525 Total revenues $ 34,002 $ 33,380 $ 102,525 $ 112,789 Gross profit (loss) Direct selling $ 20,429 $ 19,749 $ 61,425 $ 64,744 Commercial coffee (407 ) (163 ) (1,187 ) 7,393 Commercial hemp (268 ) 152 (651 ) 130 Total gross profit $ 19,754 $ 19,738 $ 59,587 $ 72,267 Operating income (loss) Direct selling $ (1,180 ) $ (3,997 ) $ (4,259 ) $ (17,090 ) Commercial coffee (1,249 ) (2,336 ) (4,652 ) 390 Commercial hemp (2,233 ) (2,146 ) (6,280 ) (3,574 ) Total operating income (loss) $ (4,662 ) $ (8,479 ) $ (15,191 ) $ (20,274 ) Net income (loss) Direct selling $ (1,271 ) $ (4,332 ) $ (4,556 ) $ (18,959 ) Commercial coffee (1,555 ) (1,397 ) (4,526 ) 2,142 Commercial hemp (2,246 ) (2,145 ) (6,321 ) (3,606 ) Total net loss $ (5,072 ) $ (7,874 ) $ (15,403 ) $ (20,423 ) Capital expenditures Direct selling $ 15 $ 594 $ 266 $ 674 Commercial coffee 1,516 181 2,977 3,596 Commercial hemp 30 1,127 699 2,609 Total capital expenditures $ 1,561 $ 1,902 $ 3,942 $ 6,879 Capital expenditures acquired through acquisitions Direct selling $ - $ - $ - $ - Commercial coffee - - - - Commercial hemp $ - $ - $ - $ 1,133 Total capital expenditures acquired through acquisitions - - - 1,133 September 30, 2020 December 31, 2019 (unaudited) Total assets Direct selling $ 38,349 $ 43,221 Commercial coffee 36,302 34,348 Commercial hemp 10,907 12,122 Total assets $ 85,558 $ 89,691 Total net property and equipment assets located outside the U.S. were approximately $7,477,000 and $7,787,000 at September 30, 2020 December 31, 2019, The Company conducts its operations primarily in the U.S. For the three September 30, 2020 2019 nine September 30, 2020 2019, The following table displays revenues attributable to the geographic location of the customer (in thousands): Three Months Ended Nine Months Ended September 30, September 30, 2020 2019 2020 2019 (unaudited) (unaudited) (unaudited) (unaudited) Revenues United States $ 28,522 $ 28,004 $ 85,814 $ 96,421 International 5,480 5,376 16,711 16,368 Total revenues $ 34,002 $ 33,380 $ 102,525 $ 112,789

Note 13 - Subsequent Events

Note 13 - Subsequent Events	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
Subsequent Events [Text Block]	Note 13. Subsequent Events Line of Credit In January 2022, second second may not In February 2022, September 30, 2021 December 31, 2021, In April 2022, June 30, 2022, 10 not June 17, 2022, Daniel Mangless - Settlement Agreement Effective February 2021, 5% 13G March 2021. In April 2021, February 2021, Mangless v. Youngevity International, Inc. and CLR Roasters LLC, Case No. 2021 996 five Pursuant to the Settlement Agreement, the Company made a payment of approximately $195,000 to Mr. Mangless in April 2021 May 2021, January 2022. December 31, 2020, 1 60 Small Business Administration Paycheck Protection Program Loan In November 2020, In February 2021, March April 2021 not In April 2021, third 1% 60 not In June 2021, April 2020 At the filing date of this Quarterly Report on Form 10 2019 In February 2021, “2019 2019 February 2019. 2019 2019 2019 one February 2022 2019 2019 10 2019 In March 2021, “2019 2019 February March 2019. 2019 2019 2019 one February March 2022, 2019 2019 10 2019 2019 In February 2021, “2019 2019 March 2019. 2019 2019 May 2022 2019 2019 one two 10 2019 Lending Agreements In May 2022, January 2024. In September 2021, November 2022. In December 2020, two one In December 2020, one 10 Cannooba Joint Venture In April 2021, At the time of this filing, the Cannooba Joint Venture was in the pre-launch phase and is expected to launch by the end of the second 2022. H&H MA Agreement In March 2021, one 2020. The MA Agreement memorialized the key settlement terms and established that H&H owes CLR approximately $10,700,000 that is composed of: ● past due accounts receivable owed to CLR from H&H Export for 2019 2020; ● the $5,000,000 note due plus accrued interest on the note; ● CLR lost profits in 2019 2020; ● the return of working capital provided by CLR for the 2019 2020 The agreement also includes an offset against amounts owed by H&H to CLR consisting of: ● H&H’s 25% profit sharing participation for 2019 2020; ● and an offset of H&H’s open payables owed by CLR to H&H in the amount of approximately $243,000. The MA Agreement provides that approximately $10,700,000 is owed to CLR by H&H Export and H&H agrees to satisfy this obligation by providing CLR a minimum of 20 825,000 March 2021 not December 31, 2020 Properties Sold and Held for Sale In February 2021, not As a result, the following transactions occurred: ● The Groveland property was sold in May 2021 ● the Mascotte facility was sold in October 2021 ● the Clermont property was sold in February 2022 The remaining balances of the notes payable associated with the above properties were paid off at the time of sale. Location Shutdowns During 2021, no Restricted Stock Units In August 2021, August 2017 Dividends During the last three 2020, three 2020. fifteenth three 2020 During 2021, 2021. fifteenth 10 2021 During 2022, December 2021, January 2022, ( January 2022, February 2022, ( February 2022, March 2022, ( March 2022, April 2022, ( April 2022, May 2022, May 2022, June 15, 2022. 2022.

Significant Accounting Policies

Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim financial information. Accordingly, certain information and footnote disclosures, normally included in financial statements prepared in accordance with generally accepted accounting principles, have been condensed or omitted pursuant to such rules and regulations. Youngevity International, Inc. (the “Company”) consolidates all wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. The condensed consolidated financial statements presented as of September 30, 2020 three nine September 30, 2020 2019 not 10 December 31, 2019, June 25, 2021. not
Segment Reporting, Policy [Policy Text Block]	Segment Information The Company has three reportable segments: direct selling, commercial coffee, and commercial hemp. The direct selling segment develops and distributes health and wellness products through its global independent direct selling network also known as multi-level marketing. The commercial coffee segment is engaged in coffee roasting and distribution, specializing in gourmet coffee. The commercial hemp segment manufactures proprietary systems to provide end-to-end extraction and processing that allow for the conversion of hemp feed stock into hemp oil and hemp extracts. The determination that the Company has three 280, Segment Reporting. During the three September 30, 2020, three September 30, 2019, During the nine September 30, 2020, nine September 30, 2019,
Use of Estimates, Policy [Policy Text Block]	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expense for each reporting period. Estimates are used in accounting for, among other things, allowances for doubtful accounts, deferred taxes and related valuation allowances, fair value of derivative liabilities, uncertain tax positions, loss contingencies, fair value of options granted under the Company’s stock-based compensation plan, fair value of assets and liabilities acquired in business combinations, finance leases, asset impairments, estimates of future cash flows used to evaluate impairments, useful lives of property, equipment and intangible assets, value of contingent acquisition debt, inventory obsolescence, and sales returns. Actual results may may
Liquidity and Going Concern [Policy Text Block]	Liquidity and Going Concern The accompanying consolidated financial statements have been prepared and presented on a basis assuming the Company will continue as a going concern. The Company has sustained significant net losses during the nine September 30, 2020 2019 nine September 30, 2020 2019, Management has assessed the Company’s ability to continue as a going concern and concluded that additional capital will be required during the twelve 10 no The Company has and continues to take actions to alleviate the cash used in operations. During the nine September 30 2020, not The outbreak of COVID- 19 19. 19 not may may In addition, the outbreak of the COVID- 19 not 19 The Company continues to seek and obtain equity or debt financing on terms that are acceptable to the Company. Depending on market conditions, there can be no These financial statements have been prepared on a going concern basis, which asserts the Company has the ability in the near term to continue to realize its assets and discharge its liabilities and commitments in a planned manner giving consideration to the above and expected possible outcomes. The financial statements do not 19 not may Actual results may may
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and Cash Equivalents The Company considers only its monetary liquid assets with original maturities of three
Revenue from Contract with Customer [Policy Text Block]	Revenue Recognition The Company recognizes revenue from product sales when the following five Revenue is recognized upon transfer of control of promised products or services to customers in an amount that reflects the consideration the Company expects to receive in exchange for those products or services. The Company enters into contracts that can include various combinations of products and services, which are generally capable of being distinct and accounted for as separate performance obligations. Revenue is recognized net of allowances for returns and any taxes collected from customers, which are subsequently remitted to governmental authorities. The transaction price for all sales is based on the price reflected in the individual customer's contract or purchase order. Variable consideration has not Independent distributors receive compensation which is recognized as distributor compensation in the Company’s consolidated statements of operations. Due to the short-term nature of the contract with the customers, the Company accrues all distributor compensation expense in the month earned and pays the compensation the following month. The Company also charges fees to become a distributor, and earn a position in the network genealogy, which are recognized as revenue in the period received. The Company’s distributors are required to pay a one no The Company has determined that most contracts will be completed in less than one one 606 10 32 18. not one one no Revenue recognition by segment is as follows: Direct Selling. Revenue is recognized when the Company satisfies its performance obligations under the contract. The Company recognizes revenue by transferring the promised products to the customer, with revenue recognized at shipping point, the point in time the customer obtains control of the products. The majority of the Company’s contracts have a single performance obligation and are short term in nature. Sales taxes in domestic and foreign jurisdictions are collected from customers and remitted to governmental authorities, all at the local level, and are accounted for on a net basis and therefore are excluded from revenues. Commercial Coffee - Roasted Coffee. Revenue is recognized when the title and risk of loss is passed to the customer under the terms of the shipping arrangement, typically, FOB shipping point. At this point the customer has a present obligation to pay, takes physical possession of the product, takes legal title to the product, bears the risks and rewards of ownership, and as such, revenue will be recognized at this point in time. Sales taxes in domestic and foreign jurisdictions are collected from customers and remitted to governmental authorities, all at the local level, and are accounted for on a net basis and therefore are excluded from revenues. Commercial Coffee - Green Coffee. Revenue is recognized when the title and risk of loss is passed to the customer under the terms of the shipping arrangement, typically, FOB shipping point. At this point the customer has a present obligation to pay, takes physical possession of the product, takes legal title to the product, bears the risks and rewards of ownership, and as such, revenue will be recognized at this point in time. Revenues where the Company sells green coffee beans that it has milled and where the Company has determined it is the agent with regard to the green coffee beans is recorded at net or recorded to reflect only the milling services provided. Sales taxes in domestic and foreign jurisdictions are collected from customers and remitted to governmental authorities, all at the local level, and are accounted for on a net basis and therefore are excluded from revenues. Commercial Hemp. Revenue is recognized when the title and risk of loss is passed to the customer under the terms of the shipping arrangement, typically, FOB shipping point. At this point the customer has a present obligation to pay, takes physical possession of the product, takes legal title to the product, bears the risks and rewards of ownership, and as such, revenue will be recognized at this point in time. Sales taxes in domestic and foreign jurisdictions are collected from customers and remitted to governmental authorities, all at the local level, and are accounted for on a net basis and therefore are excluded from revenues. Contract Balances. may Contract liabilities are reflected as deferred revenues and customer deposits in accrued expenses, deferred revenue, other current liabilities and other long-term liabilities on the Company’s consolidated balance sheets. Contract liabilities relate to payments invoiced or received in advance of completion of performance obligations and are recognized as revenue upon the fulfillment of performance obligations. The Company recognizes deferred revenue in its direct selling, commercial coffee and commercial coffee segments. In January 2020, The deferred revenue related to Heritage Maker’s product line obligation for points purchased by customers represents cash payments received that have not 2020 not The Company also records deferred revenue within its direct selling, commercial coffee and commercial hemp segments related to payments made by customers for unshipped orders. Deferred costs relate to Heritage Makers prepaid commissions are recorded in prepaid expenses and other current assets on the Company’s consolidated balance sheets and recognized in expense at the time the related revenue is recognized. Plantation Costs The Company’s commercial coffee segment includes the results of Siles, which is comprised of (i) a 500-acre coffee plantation and (ii) a dry-processing facility located on 26 acres, both of which are located in Matagalpa, Nicaragua. Siles is a wholly-owned subsidiary of CLR, and the results of CLR include the depreciation and amortization of capitalized costs, development and maintenance and harvesting costs of Siles. In accordance with GAAP, plantation maintenance and harvesting costs for commercially producing coffee farms are charged against earnings when sold. Deferred harvest costs accumulate and are capitalized throughout the year and are expensed over the remainder of the year as the coffee is sold. The difference between actual harvest costs incurred and the amount of harvest costs recognized as expense is recorded as either an increase or decrease in deferred harvest costs, which is reported as an asset and included with prepaid expenses and other current assets in the condensed consolidated balance sheets. Once the harvest is complete, the harvest costs are then recognized as the inventory value. There were no deferred costs associated with the harvest at September 30, 2020. December 31, 2019 $350,000.
Share-Based Payment Arrangement [Policy Text Block]	Stock-based Compensation The Company accounts for stock-based compensation in accordance with ASC Topic 718, Compensation Stock Compensation, The Company uses the Black-Scholes to estimate the fair value of stock options. The use of a valuation model requires the Company to make certain assumptions with respect to selected model inputs. Expected volatility is calculated based on the historical volatility of the Company’s stock price over the expected term of the option. The expected life is based on the contractual life of the option and expected employee exercise and post-vesting employment termination behavior. The risk-free interest rate is based on U.S. Treasury zero
Income Tax, Policy [Policy Text Block]	Income Taxes The Company accounts for income taxes in accordance with ASC Topic 740, "Income Taxes," not Income taxes for the interim periods are computed using the effective tax rates estimated to be applicable for the full fiscal year, as adjusted for any discrete taxable events that occur during the period. The Company files income tax returns in the U.S. on a federal basis and in many U.S. state and foreign jurisdictions. Certain tax years remain open to examination by the major taxing jurisdictions to which the Company is subject.
Commitments and Contingencies, Policy [Policy Text Block]	Commitments and Contingencies The Company is from time to time, the subject of claims and suits arising out of matters related to the Company’s business. The Company is party to litigation at the present time and may not
Earnings Per Share, Policy [Policy Text Block]	Basic and Diluted Net Loss Per Share Basic loss per share is computed by dividing net loss attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted loss per share is computed by dividing net loss attributable to common stockholders by the sum of the weighted-average number of common shares outstanding during the period and the weighted-average number of dilutive common share equivalents outstanding during the period, using the treasury stock method. Dilutive common share equivalents are comprised of stock options, restricted stock, warrants, convertible preferred stock and common stock associated with the Company's convertible notes based on the average stock price for each period using the treasury stock method. Potentially dilutive shares are excluded from the computation of diluted net loss per share when their effect is anti-dilutive. In periods where a net loss is presented, all potentially dilutive securities are anti-dilutive and are excluded from the computation of diluted net loss per share. Potentially dilutive securities for the periods ended September 30, 2020 2019 September 30, 2020 2019 (unaudited) (unaudited) Warrants 5,266,187 6,238,182 Preferred stock conversions 22,786 275,600 Principal conversions on convertible notes 309,000 312,571 Stock options 4,567,368 3,705,644 Restricted stock units 429,443 456,111 Total 10,594,784 10,988,108 The calculation of diluted loss per share requires that, to the extent the average market price of the underlying shares for the reporting period exceeds the exercise price of the warrants and the presumed exercise of such securities are dilutive to loss per share for the period, an adjustment to net loss used in the calculation is required to remove the change in fair value of the warrants, net of tax from the numerator for the period. Likewise, an adjustment to the denominator is required to reflect the related dilutive shares, if any, under the treasury stock method. During the three nine September 30, 2019, Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 (unaudited) (unaudited) (unaudited) (unaudited) Loss per Share Basic Numerator for basic loss per share $ (5,434,000 ) $ (7,959,000 ) $ (16,507,000 ) $ (20,550,000 ) Denominator for basic loss per share 32,233,622 30,035,182 31,479,884 28,924,305 Loss per common share - basic $ (0.17 ) $ (0.27 ) $ (0.52 ) $ (0.71 ) Loss per Share - Diluted Numerator for basic loss per share $ (5,434,000 ) $ (7,959,000 ) $ (16,507,000 ) $ (20,550,000 ) Adjust: Fair value of dilutive warrants outstanding - (27,000 ) - (1,529,000 ) Numerator for dilutive loss per share $ (5,434,000 ) $ (7,986,000 ) $ (16,507,000 ) $ (22,079,000 ) Denominator for basic loss per share 32,233,622 30,035,182 31,479,884 28,924,305 Plus: Incremental shares underlying “in the money” warrants outstanding - 4,494 - 79,026 Denominator for dilutive loss per share 32,233,622 30,039,676 31,479,884 29,003,331 Loss per common share - diluted $ (0.17 ) $ (0.27 ) $ (0.52 ) $ (0.76 )
New Accounting Pronouncements, Policy [Policy Text Block]	Recently Issued and Adopted Accounting Pronouncements The Company does not not nine September 30, 2020, not

Note 1 - Description of Busin_2

Note 1 - Description of Business and Basis of Presentation (Tables)	9 Months Ended
	Sep. 30, 2020
Notes Tables
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	September 30, 2020 2019 (unaudited) (unaudited) Warrants 5,266,187 6,238,182 Preferred stock conversions 22,786 275,600 Principal conversions on convertible notes 309,000 312,571 Stock options 4,567,368 3,705,644 Restricted stock units 429,443 456,111 Total 10,594,784 10,988,108
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 (unaudited) (unaudited) (unaudited) (unaudited) Loss per Share Basic Numerator for basic loss per share $ (5,434,000 ) $ (7,959,000 ) $ (16,507,000 ) $ (20,550,000 ) Denominator for basic loss per share 32,233,622 30,035,182 31,479,884 28,924,305 Loss per common share - basic $ (0.17 ) $ (0.27 ) $ (0.52 ) $ (0.71 ) Loss per Share - Diluted Numerator for basic loss per share $ (5,434,000 ) $ (7,959,000 ) $ (16,507,000 ) $ (20,550,000 ) Adjust: Fair value of dilutive warrants outstanding - (27,000 ) - (1,529,000 ) Numerator for dilutive loss per share $ (5,434,000 ) $ (7,986,000 ) $ (16,507,000 ) $ (22,079,000 ) Denominator for basic loss per share 32,233,622 30,035,182 31,479,884 28,924,305 Plus: Incremental shares underlying “in the money” warrants outstanding - 4,494 - 79,026 Denominator for dilutive loss per share 32,233,622 30,039,676 31,479,884 29,003,331 Loss per common share - diluted $ (0.17 ) $ (0.27 ) $ (0.52 ) $ (0.76 )

Note 2 - Acquisitions and Bus_2

Note 2 - Acquisitions and Business Combinations (Tables) - BeneYOU [Member]	9 Months Ended
	Sep. 30, 2020
Notes Tables
Schedule of Business Acquisitions, by Acquisition [Table Text Block]	Contingent consideration $ 2,648 Aggregate purchase price $ 2,648 Present value of cash consideration $ 1,894 Estimated fair value of common stock issued 14,000 Aggregate purchase price $ 15,894
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]	Current assets (excluding inventory) $ 408 Inventory (net of $469 441 Trademarks and trade name 343 Distributor organization 1,175 Customer relationships 44 Non-compete agreement 277 Goodwill 669 Current liabilities (709 ) Net assets acquired $ 2,648 Current assets $ 636 Inventory 1,264 Property, plant and equipment 1,133 Trademarks and trade name 1,876 Customer-related intangible 5,629 Non-compete intangible 956 Goodwill 6,831 Current liabilities (1,904 ) Notes payable (527 ) Net assets acquired $ 15,894

Note 4 - Revenue Recognition (T

Note 4 - Revenue Recognition (Tables)	9 Months Ended
	Sep. 30, 2020
Notes Tables
Disaggregation of Revenue [Table Text Block]	Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 (unaudited) (unaudited) (unaudited) (unaudited) Direct selling $ 31,319 $ 30,256 $ 92,750 $ 95,800 Processed green coffee 254 (22 ) 773 1,046 Milling and processing services 211 29 535 6,416 Roasted coffee and other 2,017 2,933 7,467 9,002 Commercial coffee 2,482 2,940 8,775 16,464 Commercial hemp 201 184 1,000 525 Total revenue $ 34,002 $ 33,380 $ 102,525 $ 112,789
Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]	September 30, 2020 December 31, 2019 (unaudited) Accrued expenses $ 627 $ - Deferred revenue 8,527 1,943 Other current liabilities 1,800 1,626 Deferred revenue, total $ 10,954 $ 3,569

Note 5 - Selected Consolidate_2

Note 5 - Selected Consolidated Balance Sheet Information (Tables)	9 Months Ended
	Sep. 30, 2020
Notes Tables
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]	September 30, 2020 December 31, 2019 (unaudited) Accounts receivable $ 11,253 $ 11,142 Allowance for doubtful accounts (8,210 ) (8,240 ) Accounts receivable, net $ 3,043 $ 2,902
Schedule of Inventory, Current [Table Text Block]	September 30, 2020 December 31, 2019 (unaudited) Finished goods $ 12,448 $ 14,890 Raw materials 13,382 11,694 Total inventory 25,830 26,584 Reserve for excess and obsolete (3,794 ) (3,878 ) Inventory, net $ 22,036 $ 22,706
Property, Plant and Equipment [Table Text Block]	September 30, 2020 December 31, 2019 (unaudited) Buildings $ 4,117 $ 4,789 Leasehold improvements 3,148 2,948 Land 2,544 3,307 Land improvements 606 606 Producing coffee trees 553 553 Manufacturing equipment 10,464 9,568 Furniture and other equipment 2,062 2,050 Computer software 1,442 1,420 Computer equipment 2,714 2,648 Vehicles 326 326 Assets held for sale (1) 1,496 - Construction in process 9,133 6,562 Total property and equipment, gross 38,605 34,777 Accumulated depreciation (13,416 ) (11,461 ) Total property and equipment, net $ 25,189 $ 23,316
Lessee, Operating Lease and Financing Lease [Table Text Block]	September 30, 2020 December 31, 2019 (unaudited) Assets Operating lease right-of-use assets $ 6,467 $ 8,386 Finance lease right-of-use assets (1) 882 1,052 Total leased assets 7,349 $ 9,438 Liabilities Operating lease liabilities, current portion $ 1,290 $ 1,740 Finance lease liabilities, current portion 1,703 736 Total leased liabilities, current portion 2,993 2,476 Operating lease liabilities, net of current portion 5,497 6,646 Finance lease liabilities, net of current portion 1,081 408 Total lease liabilities $ 9,571 $ 9,530 September 30, 2020 December 31, 2019 (unaudited) Weighted-average remaining lease term (in years) Operating leases 6.7 6.8 Finance leases 1.7 1.6 Weighted-average discount rate Operating leases 5.41 % 5.47 % Finance leases 17.63 % 4.57 %
Lease, Cost [Table Text Block]	Three Months Ended Nine Months Ended September 30, September 30, 2020 2019 2020 2019 (unaudited) (unaudited) (unaudited) (unaudited) Operating lease cost (1) $ 495 $ 420 $ 1,591 $ 962 Finance lease cost: Amortization of leased assets (2) 311 84 703 274 Interest on lease liabilities (3) 18 30 66 101 Total operating and finance lease cost $ 824 $ 534 $ 2,360 $ 1,337
Schedule of Finite-Lived Intangible Assets [Table Text Block]	September 30, 2020 (unaudited) December 31, 2019 Cost Accumulated Amortization Net Cost Accumulated Amortization Net Distributor organizations $ 15,735 $ 11,090 $ 4,645 $ 15,735 $ 10,418 $ 5,317 Trademarks and trade names 8,430 3,070 5,360 8,430 2,539 5,891 Customer relationships 10,442 6,934 3,508 10,442 6,413 4,029 Internally developed software 720 720 - 720 657 63 Non-compete agreement 277 64 213 277 11 266 Intangible assets $ 35,604 $ 21,878 $ 13,726 $ 35,604 $ 20,038 $ 15,566
Schedule of Goodwill [Table Text Block]	September 30, 2020 December 31, 2019 (unaudited) Direct selling $ 3,678 $ 3,678 Commercial coffee 3,314 3,314 Commercial hemp - - Total goodwill $ 6,992 $ 6,992

Note 7 - Convertible Notes Pa_2

Note 7 - Convertible Notes Payable (Tables)	9 Months Ended
	Sep. 30, 2020
Notes Tables
Convertible Debt [Table Text Block]	September 30, 2020 December 31, 2019 (unaudited) 6.00% $ 3,090 $ 3,090 Debt discounts (163 ) (415 ) Carrying value of 2019 PIPE Notes 2,927 2,675 8.00% – 25 Debt discounts – – Carrying value of 2014 PIPE Notes – 25 Total carrying value of convertible notes payable $ 2,927 $ 2,700

Note 8 - Derivative Liability (

Note 8 - Derivative Liability (Tables)	9 Months Ended
	Sep. 30, 2020
Notes Tables
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]	December 31, 2019 Stock price volatility 64.10 % Risk-free interest rates 1.59% – 1.60 % Annual dividend yield – Expected life (in years) 0.6 – 1.0

Note 9 - Fair Value of Financ_2

Note 9 - Fair Value of Financial Instruments (Tables)	9 Months Ended
	Sep. 30, 2020
Notes Tables
Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]	Fair Value at September 30, 2020 (unaudited) Total Level 1 Level 2 Level 3 Liabilities: Contingent acquisition debt, current portion $ 1,341 $ - $ - $ 1,341 Contingent acquisition debt, less current portion 5,455 - - 5,455 Warrant derivative liability - - - - Total derivative liabilities $ 6,796 $ - $ - $ 6,796 Fair Value at December 31, 2019 Total Level 1 Level 2 Level 3 Liabilities: Contingent acquisition debt, current portion $ 1,263 $ - $ - $ 1,263 Contingent acquisition debt, less current portion 7,348 - - 7,348 Warrant derivative liability 1,542 - - 1,542 Total derivative liabilities $ 10,153 $ - $ - $ 10,153
Schedule of Derivative Liabilities at Fair Value [Table Text Block]	Balance at December 31, 2019 $ 1,542 Adjustments to estimated fair value (1,542 ) Balance at September 30, 2020 (unaudited) $ -
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	Balance at December 31, 2019 $ 8,611 Liabilities settled (175 ) Adjustments to liabilities included in earnings (1,640 ) Balance at September 30, 2020 (unaudited) $ 6,796

Note 10 - Stockholders' Equity

Note 10 - Stockholders' Equity (Tables)	9 Months Ended
	Sep. 30, 2020
Notes Tables
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	Number of Warrants Outstanding at December 31, 2019 6,238,182 Issued 250,000 Expired / cancelled (1,221,995 ) Exercised - Outstanding at September 30, 2020 (unaudited) 5,266,187
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]	Three Months Ended September 30, Nine Months Ended September 30, (unaudited) (unaudited) (unaudited) (unaudited) 2020 2019 2020 2019 Cost of revenues $ 5 $ 6 $ 16 $ 89 Sales and marketing 31 33 92 563 General and administrative 216 622 669 11,766 Total stock-based compensation $ 252 $ 661 $ 777 $ 12,418
Share-Based Payment Arrangement, Option, Activity [Table Text Block]	Number of Shares Weighted Average Exercise Price Weighted Average Remaining Contract Life (years) Aggregate Intrinsic Value (in thousands) Outstanding December 31, 2019 4,637,642 $ 5.63 7.8 $ - Granted - - Canceled / expired (70,274 ) 4,88 Exercised - - - Outstanding September 30, 2020 (unaudited) 4,567,368 $ 5.64 7.1 $ - Exercisable September 30, 2020 (unaudited) 4,219,877 $ 5.71 7.1 $ -
Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]	Number of Shares Balance at December 31, 2019 451,944 Issued - Canceled (10,000 ) Vested (52,251 ) Balance at September 30, 2020 (unaudited) 389,693

Note 12 - Segment and Geograp_2

Note 12 - Segment and Geographical Information (Tables)	9 Months Ended
	Sep. 30, 2020
Notes Tables
Schedule of Segment Reporting Information, by Segment [Table Text Block]	Three Months Ended Nine Months Ended September 30, September 30, 2020 2019 2020 2019 (unaudited) (unaudited) (unaudited) (unaudited) Revenues Direct selling $ 31,319 $ 30,256 $ 92,750 $ 95,800 Commercial coffee 2,482 2,940 8,775 16,464 Commercial hemp 201 184 1,000 525 Total revenues $ 34,002 $ 33,380 $ 102,525 $ 112,789 Gross profit (loss) Direct selling $ 20,429 $ 19,749 $ 61,425 $ 64,744 Commercial coffee (407 ) (163 ) (1,187 ) 7,393 Commercial hemp (268 ) 152 (651 ) 130 Total gross profit $ 19,754 $ 19,738 $ 59,587 $ 72,267 Operating income (loss) Direct selling $ (1,180 ) $ (3,997 ) $ (4,259 ) $ (17,090 ) Commercial coffee (1,249 ) (2,336 ) (4,652 ) 390 Commercial hemp (2,233 ) (2,146 ) (6,280 ) (3,574 ) Total operating income (loss) $ (4,662 ) $ (8,479 ) $ (15,191 ) $ (20,274 ) Net income (loss) Direct selling $ (1,271 ) $ (4,332 ) $ (4,556 ) $ (18,959 ) Commercial coffee (1,555 ) (1,397 ) (4,526 ) 2,142 Commercial hemp (2,246 ) (2,145 ) (6,321 ) (3,606 ) Total net loss $ (5,072 ) $ (7,874 ) $ (15,403 ) $ (20,423 ) Capital expenditures Direct selling $ 15 $ 594 $ 266 $ 674 Commercial coffee 1,516 181 2,977 3,596 Commercial hemp 30 1,127 699 2,609 Total capital expenditures $ 1,561 $ 1,902 $ 3,942 $ 6,879 Capital expenditures acquired through acquisitions Direct selling $ - $ - $ - $ - Commercial coffee - - - - Commercial hemp $ - $ - $ - $ 1,133 Total capital expenditures acquired through acquisitions - - - 1,133 September 30, 2020 December 31, 2019 (unaudited) Total assets Direct selling $ 38,349 $ 43,221 Commercial coffee 36,302 34,348 Commercial hemp 10,907 12,122 Total assets $ 85,558 $ 89,691
Revenue from External Customers by Geographic Areas [Table Text Block]	Three Months Ended Nine Months Ended September 30, September 30, 2020 2019 2020 2019 (unaudited) (unaudited) (unaudited) (unaudited) Revenues United States $ 28,522 $ 28,004 $ 85,814 $ 96,421 International 5,480 5,376 16,711 16,368 Total revenues $ 34,002 $ 33,380 $ 102,525 $ 112,789

Note 1 - Description of Busin_3

Note 1 - Description of Business and Basis of Presentation (Details Textual)	3 Months Ended		9 Months Ended
	Sep. 30, 2020 USD ($) a	Sep. 30, 2019 USD ($)	Sep. 30, 2020 USD ($) a shares	Sep. 30, 2019 USD ($) shares	Dec. 31, 2019 USD ($)
Number of Operating Segments			3
Number of Reportable Segments			3
Net Income (Loss) Attributable to Parent, Total	$ (5,072,000)	$ (7,874,000)	$ (15,403,000)	$ (20,423,000)
Net Cash Provided by (Used in) Operating Activities, Total			(2,075,000)	(7,762,000)
Revenue from Contract with Customer, Excluding Assessed Tax	34,002,000	33,380,000	$ 102,525,000	$ 112,789,000
Increase (Decrease) of Revenue, Percentage			9.10%
Deferred Costs, Total	$ 0		$ 0		$ 350,000
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) | shares			10,594,784	10,988,108
Derivative, Gain on Derivative		$ 27,000		$ 1,529,000
Coffee Plantation [Member]
Area of Land (Acre) | a	500		500
Dry-processing Facility [Member]
Area of Land (Acre) | a	26		26
Direct Selling Segment [Member]
Percentage of Revnue	92.10%	90.60%	90.50%	84.90%
Net Income (Loss) Attributable to Parent, Total	$ (1,271,000)	$ (4,332,000)	$ (4,556,000)	$ (18,959,000)
Revenue from Contract with Customer, Excluding Assessed Tax	$ 31,319,000	$ 30,256,000	$ 92,750,000	$ 95,800,000
Commercial Coffee Segment [Member]
Percentage of Revnue	7.30%	8.80%	8.50%	14.60%
Net Income (Loss) Attributable to Parent, Total	$ (1,555,000)	$ (1,397,000)	$ (4,526,000)	$ 2,142,000
Revenue from Contract with Customer, Excluding Assessed Tax	$ 2,482,000	$ 2,940,000	$ 8,775,000	$ 16,464,000
Commercial Hemp Segment [Member]
Percentage of Revnue	0.60%	0.60%	1%	0.50%
Net Income (Loss) Attributable to Parent, Total	$ (2,246,000)	$ (2,145,000)	$ (6,321,000)	$ (3,606,000)
Revenue from Contract with Customer, Excluding Assessed Tax	$ 201,000	$ 184,000	$ 1,000,000	$ 525,000

Note 1 - Description of Busin_4

Note 1 - Description of Business and Basis of Presentation - Anti-dilutive Securities (Details) - shares	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Antidilutive Securities (in shares)	10,594,784	10,988,108
Warrant [Member]
Antidilutive Securities (in shares)	5,266,187	6,238,182
Preferred Stock Conversions [Member]
Antidilutive Securities (in shares)	22,786	275,600
Principal Conversion on Convertible Notes [Member]
Antidilutive Securities (in shares)	309,000	312,571
Share-Based Payment Arrangement, Option [Member]
Antidilutive Securities (in shares)	4,567,368	3,705,644
Restricted Stock Units (RSUs) [Member]
Antidilutive Securities (in shares)	429,443	456,111

Note 1 - Description of Busin_5

Note 1 - Description of Business and Basis of Presentation - Earnings Per Share (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Numerator for basic loss per share	$ (5,434,000)	$ (7,959,000)	$ (16,507,000)	$ (20,550,000)
Weighted average shares outstanding, basic (in shares)	32,233,622	30,035,182	31,479,884	28,924,305
Net loss per share, basic (in dollars per share)	$ (0.17)	$ (0.27)	$ (0.52)	$ (0.71)
Adjustments to estimated fair value	$ 0	$ (27,000)	$ 0	$ (1,529,000)
Numerator for dilutive loss per share	$ (5,434,000)	$ (7,986,000)	$ (16,507,000)	$ (22,079,000)
Plus: Incremental shares underlying “in the money” warrants outstanding (in shares)	0	4,494	0	79,026
Denominator for dilutive loss per share (in shares)	32,233,622	30,039,676	31,479,884	29,003,331
Net loss per share, diluted (Note 1) (in dollars per share)	$ (0.17)	$ (0.27)	$ (0.52)	$ (0.76)

Note 2 - Acquisitions and Bus_3

Note 2 - Acquisitions and Business Combinations (Details Textual) - USD ($)				11 Months Ended
	Dec. 31, 2019	Nov. 01, 2019	Feb. 12, 2019	Dec. 31, 2019	Sep. 30, 2020
Goodwill, Ending Balance	$ 6,992,000			$ 6,992,000	$ 6,992,000
Intangible Assets, Net (Excluding Goodwill), Total	15,566,000			15,566,000	13,726,000
BeneYOU [Member]
Business Combination, Consideration Transferred, Total		$ 2,648,000
Payments to Acquire Businesses, Gross		200,000
Business Combination, Consideration Transferred, Liabilities Incurred		3,300,000
Business Combination, Contingent Consideration, Liability, Total		2,648,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill, Total		1,839,000
Goodwill, Ending Balance		$ 669,000
BeneYOU [Member] | Trademarks and Trade Names [Member]
Finite-Lived Intangible Asset, Useful Life (Year)		5 years
BeneYOU [Member] | Distributor Organization [Member]
Finite-Lived Intangible Asset, Useful Life (Year)		9 years
BeneYOU [Member] | Customer Relationships [Member]
Finite-Lived Intangible Asset, Useful Life (Year)		5 years
BeneYOU [Member] | Noncompete Agreements [Member]
Finite-Lived Intangible Asset, Useful Life (Year)		4 years
BeneYOU [Member] | Maximum [Member]
Business Combination, Consideration Transferred, Total		$ 3,500,000
AEPA With Khrysos Global [Member]
Business Combination, Consideration Transferred, Total			$ 15,894,000
Payments to Acquire Businesses, Gross			500,000
Business Combination, Consideration Transferred, Liabilities Incurred			16,000,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill, Total			8,461,000
Goodwill, Ending Balance	6,831,000			6,831,000
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable			14,000,000
Intangible Assets, Net (Excluding Goodwill), Total	8,461,000			8,461,000
AEPA With Khrysos Global [Member] | Consideration Payable in Cash [Member]
Payments to Acquire Businesses, Gross				1,000,000
Business Combination, Consideration Transferred, Liabilities Incurred	500,000		$ 1,500,000
AEPA With Khrysos Global [Member] | Consideration Payable in Cash [Member] | Accrued Expenses [Member]
Business Combination, Contingent Consideration, Liability, Total	$ 500,000			$ 500,000	$ 500,000
AEPA With Khrysos Global [Member] | Common Stock [Member]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares)			1,794,972
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable			$ 14,000,000
AEPA With Khrysos Global [Member] | Trademarks and Trade Names [Member]
Finite-Lived Intangible Asset, Useful Life (Year)			8 years
AEPA With Khrysos Global [Member] | Customer Relationships [Member]
Finite-Lived Intangible Asset, Useful Life (Year)			4 years
AEPA With Khrysos Global [Member] | Noncompete Agreements [Member]
Finite-Lived Intangible Asset, Useful Life (Year)			6 years

Note 2 - Acquisitions and Bus_4

Note 2 - Acquisitions and Business Combinations - Fair Value of Acquired Tangible and Intangible Assets and Liabilities (Details) - USD ($)	Nov. 01, 2019	Feb. 12, 2019
BeneYOU [Member]
Contingent consideration	$ 2,648,000
Aggregate purchase price	2,648,000
Present value of cash consideration	3,300,000
Aggregate purchase price	$ 2,648,000
AEPA With Khrysos Global [Member]
Aggregate purchase price		$ 15,894,000
Present value of cash consideration		16,000,000
Estimated fair value of common stock issued		14,000,000
Aggregate purchase price		15,894,000
AEPA With Khrysos Global [Member] | Contingent Consideration Payable in Cash [Member]
Present value of cash consideration		$ 1,894,000

Note 2 - Acquisitions and Bus_5

Note 2 - Acquisitions and Business Combinations - Fair Value of Assets Acquired and Liabilities Assumed (Details) - USD ($)	Sep. 30, 2020	Dec. 31, 2019	Nov. 01, 2019	Sep. 30, 2019	Feb. 12, 2019
Goodwill	$ 6,992,000	$ 6,992,000
Property, plant and equipment				$ 1,133,000
BeneYOU [Member]
Current assets (excluding inventory)			$ 408,000
Inventory (net of $469 reserve)			441,000
Goodwill			669,000
Current liabilities			(709,000)
Net assets acquired			2,648,000
Net assets acquired			2,648,000
BeneYOU [Member] | Trademarks and Trade Names [Member]
Intangibles			343,000
BeneYOU [Member] | Distributor Organization [Member]
Intangibles			1,175,000
BeneYOU [Member] | Customer Relationships [Member]
Intangibles			44,000
BeneYOU [Member] | Noncompete Agreements [Member]
Intangibles			$ 277,000
Khrysos Global [Member]
Current assets (excluding inventory)					$ 636,000
Inventory (net of $469 reserve)					1,264,000
Goodwill					6,831,000
Current liabilities					(1,904,000)
Net assets acquired					15,894,000
Property, plant and equipment					1,133,000
Notes payable					(527,000)
Net assets acquired					15,894,000
Khrysos Global [Member] | Trademarks and Trade Names [Member]
Intangibles					1,876,000
Khrysos Global [Member] | Customer Relationships [Member]
Intangibles					5,629,000
Khrysos Global [Member] | Noncompete Agreements [Member]
Intangibles					$ 956,000

Note 2 - Acquisitions and Bus_6

Note 2 - Acquisitions and Business Combinations - Fair Value of Assets Acquired and Liabilities Assumed (Details) (Parentheticals) $ in Thousands	Nov. 01, 2019 USD ($)
BeneYOU [Member]
Reserve	$ 469

Note 3 - Related Party Transa_2

Note 3 - Related Party Transactions (Details Textual)	1 Months Ended											3 Months Ended				9 Months Ended		12 Months Ended	21 Months Ended
	Apr. 30, 2021 shares	Jul. 31, 2020 USD ($) $ / shares shares	Mar. 31, 2020 USD ($) shares	Aug. 31, 2019 USD ($) shares	Jul. 31, 2019 USD ($) $ / shares shares	Jun. 30, 2019 USD ($) $ / shares shares	Mar. 31, 2019 USD ($)	Feb. 28, 2019 USD ($) $ / shares shares	Jan. 31, 2019 USD ($) a $ / shares shares	Oct. 31, 2018 USD ($) $ / shares shares	Mar. 31, 2018 shares	Sep. 30, 2020 USD ($) shares	Sep. 30, 2020 USD ($) shares	Mar. 31, 2020 USD ($) $ / lb	Sep. 30, 2019 USD ($) shares	Sep. 30, 2020 USD ($) shares	Sep. 30, 2019 USD ($) shares	Dec. 31, 2019 USD ($) shares	Sep. 30, 2020 USD ($) shares	Mar. 31, 2021 USD ($)	Dec. 31, 2020 USD ($) $ / shares shares	Dec. 31, 2018 USD ($)	May 31, 2017 $ / shares shares	Sep. 30, 2014 USD ($) $ / shares shares	Aug. 31, 2014 USD ($)
Accounts Receivable, Credit Loss Expense (Reversal)																$ (30,000)	$ 0
Prepaid Expense and Other Assets, Current												$ 5,432,000	$ 5,432,000			5,432,000		$ 3,982,000	$ 5,432,000
Stock Issued During Period, Value, New Issues															$ 7,323,000
Profit-sharing Income													$ 424,000			$ 635,000
Profit-sharing Expenses															863,000		1,331,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares												5,266,187	5,266,187			5,266,187		6,238,182	5,266,187
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number (in shares) | shares												4,219,877	4,219,877			4,219,877			4,219,877
Conversion of 2014 Convertible Note into Common Stock [Member]
Debt Conversion, Original Debt, Amount										$ 4,000,000
Debt Conversion, Converted Instrument, Shares Issued (in shares) | shares										747,664
Warrants With Hemp Joint Venture Agreement [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares		5,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares		$ 1.50
Warrants and Rights Outstanding, Term (Year)		5 years
Warrants With 2014 Convertible Note [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares										631,579		631,579	631,579			631,579		631,579	631,579
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares										$ 4.75
Warrants and Rights Outstanding, Term (Year)										4 years
Warrants With 2014 Private Placement [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares																								929,346
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares																								$ 4.60
Shares With Hemp Joint Venture Agreement [Member]
Stock Issued During Period, Shares, New Issues (in shares) | shares		1,500,000
Stock Issued During Period, Value, New Issues		$ 2,490,000														$ 2,490,000
CLR [Member]
Ownership Percentage									50%
Construction Contract, Amount of Contribution									$ 4,700,000
Profit-sharing Amount, Additional Increase, Percent									25%
Profit-sharing Split, Percent									75%
CLR [Member] | Credit Note [Member]
Debt Instrument, Face Amount																						$ 5,000,000
CLR [Member] | Construction of Matagalpa Mill Project [Member]
Related Party Transaction, Amounts of Transaction													$ 706,000			1,506,000	2,150,000		$ 4,556,000
CLR [Member] | Operating Equipment [Member]
Related Party Transaction, Amounts of Transaction																			1,304,000
Nicaraguan Partner [Member] | Construction of Matagalpa Mill Project [Member]
Related Party Transaction, Amounts of Transaction																			2,528,000
H&H [Member] | CLR [Member]
Related Party Transaction, Purchases from Related Party													1,072,000			2,847,000
H&H [Member] | CLR [Member] | Forecast [Member]
Notes Receivable, Related Parties																				$ 5,000,000
Financing Receivable, Allowance for Credit Loss, Ending Balance																					$ 5,789,000
Profit-sharing Split, Percent																				25%
H&H [Member] | CLR [Member] | Green Coffee Acquisition [Member]
Prepaid Expense and Other Assets, Current												$ 1,017,000	1,017,000			1,017,000			1,017,000
H&H [Member] | CLR [Member] | Billing for Freight and Other Charges [Member]
Accounts Payable, Related Parties												230,000	230,000			230,000			230,000
H&H [Member] | CLR [Member] | Mill Operation Cost [Member]
Accrued Liabilities, Total												544,000	544,000			544,000			544,000
H&H [Member] | CLR [Member] | Green Coffee Sold But Not Delivered [Member]
Accrued Liabilities, Total												994,000	994,000			994,000			994,000
H&H Export [Member]
Stock Issued During Period, Shares, New Issues (in shares) | shares									153,846
Stock Issued During Period, Value, New Issues									$ 1,200,000
Stock Issued During Period, Shares, New Issues for Working Capital and Payables (in shares) | shares									295,910
Stock Issued During Period, Shares, Over Issues (in shares) | shares									121,649
Stock Issued During Period, Shares, Net Issues for Working Capital and Payables (in shares) | shares									174,261
Stock Issued During Period, Value, New Issued for Working Capital and Payables																73,000		$ 397,000
H&H Export [Member] | CLR [Member]
Related Party Transaction, Purchases from Related Party													229,000			700,000	2,828,000
Revenue from Related Parties												211,000			29,000	535,000	6,416,000
Accounts Receivable, Related Parties			$ 30,100,000											$ 30,100,000
Accounts Receivable, Credit Loss Expense (Reversal)																7,871,000		7,871,000
Related Party Transaction, Additional Payment Amount (in USD per Pound) | $ / lb														0.225
Notes Receivable, Related Parties							$ 5,000,000															$ 5,000,000
Receivable, Stated Interest Rate							9%
Financing Receivable, Allowance for Credit Loss, Ending Balance												5,677,000	5,677,000			5,677,000		5,340,000	5,677,000
H&H Export [Member] | CLR [Member] | Shares Issued for Purchase Consideration [Member]
Stock Issued During Period, Shares, New Issues (in shares) | shares									100,000
Shares Issued, Price Per Share (in dollars per share) | $ / shares									$ 7.50
H&H Export [Member] | CLR [Member] | Customer Related Revenue Receivables [Member]
Accounts Receivable, Related Parties												7,871,000	7,871,000			7,871,000		8,707,000	7,871,000
H&H Export Group [Member] | Nicaraguan Agency [Member]
Accounts Receivable, Related Parties			22,000,000											$ 22,000,000
Line of Credit Facility, Maximum Borrowing Capacity			$ 46,500,000											46,500,000
Nicaraguan Partner [Member]
Ownership Percentage									50%
Construction Contract, Amount of Contribution									$ 4,700,000
Profit-sharing Split, Percent									25%
Nicaraguan Partner [Member] | CLR [Member] | Matagalpa Property [Member]
Area of Land (Acre) | a									45
Nicaraguan JV Partners [Member]
Profit-sharing Split, Percent		25%
U.S. Partners [Member]
Profit-sharing Split, Percent		75%
Mr. Hernandez [Member] | CLR [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares																							75,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares																							$ 2
Warrants and Rights Outstanding, Term (Year)																							3 years
WVNP [Member]
Related Party Transaction, Purchases from Related Party														56,000	$ 8,000		$ 120,000
WVNP [Member] | Distributor Commission [Member]
Related Party Transaction, Purchases from Related Party														81,000
Mr. Grover [Member] | Credit Note [Member]
Long-Term Debt, Total												$ 4,763,000	$ 4,763,000			$ 4,763,000		4,085,000	$ 4,763,000
Mr. Grover [Member] | Warrants With 2014 Convertible Note [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares					782,608	782,608
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares					$ 4.60
Stock Issued During Period, Shares, Warrants Exercised (in shares) | shares					600,242
Proceeds from Warrant Exercises					$ 2,761,000
Stock Issued During Period, Shares, for Inducement Shares (in shares) | shares					50,000
Mr. Grover [Member] | Warrants With 2014 Convertible Note [Member] | Forecast [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares																					182,366
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares																					$ 4.75
Paul Sallwasser [Member]
Related Party Transaction, Amounts of Transaction				$ 8,000
Stock Issued During Period, Shares, Warrants Exercised (in shares) | shares				14,673
Proceeds from Warrant Exercises				$ 67,000
Number of Common Stock and Options Outstanding (in shares) | shares												76,924	76,924		76,924	76,924	76,924		76,924
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number (in shares) | shares												116,655	116,655		116,655	116,655	116,655		116,655
Paul Sallwasser [Member] | Conversion of 2014 Convertible Note into Common Stock [Member]
Debt Conversion, Original Debt, Amount																$ 75,000
Debt Conversion, Converted Instrument, Shares Issued (in shares) | shares																10,714
Paul Sallwasser [Member] | Conversion of 2017 Convertible Private Placement Note into Common Stock [Member]
Debt Conversion, Original Debt, Amount																$ 38,000
Debt Conversion, Converted Instrument, Shares Issued (in shares) | shares																8,177
Paul Sallwasser [Member] | Conversion of 2017 Convertible Note into Common Stock [Member]
Debt Conversion, Original Debt, Amount																$ 5,000
Debt Conversion, Converted Instrument, Shares Issued (in shares) | shares											9,264					1,087
Paul Sallwasser [Member] | Warrants With 2014 Private Placement [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares												14,673	14,673			14,673			14,673
Paul Sallwasser [Member] | Warrants With 2017 Private Placement [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares												5,719	5,719			5,719			5,719
Paul Sallwasser [Member] | Warrants With 2017 Convertible Note [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares											6,262	543	543			543			543
Mr. Daniel Mangless [Member]
Stock Issued During Period, Shares, New Issues (in shares) | shares			50,000			250,000		250,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares								250,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares								$ 7
Warrants and Rights Outstanding, Term (Year)								3 years
Shares Issued, Price Per Share (in dollars per share) | $ / shares						$ 5.50		$ 7
Proceeds from Issuance or Sale of Equity, Total						$ 1,375,000		$ 1,750,000
Debt Instrument, Face Amount			$ 1,000,000											$ 1,000,000
Mr. Daniel Mangless [Member] | Forecast [Member]
Stock Issued During Period, Shares, New Issues (in shares) | shares	1,000,000
JJE Equipment [Member]
Deposit Assets, Total												$ 230,000	$ 230,000			$ 230,000		233,000	$ 230,000
Youngevity Be the Change Foundation [Member]
Related Party Transaction, Amounts of Transaction													22,000		$ 24,000	92,000	$ 82,000
Youngevity Be the Change Foundation [Member] | Current Liabilities [Member]
Due to Related Parties, Current, Total												$ 444,000	$ 444,000			$ 444,000		357,000	$ 444,000
Daniel Briskie and Maida Briskie [Member] | Private Placement 2014 [Member]
Long-Term Debt, Total																		$ 25,000
Debt Instrument, Face Amount																								$ 25,000
Douglas Briskie [Member] | Private Placement 2014 [Member]
Debt Instrument, Face Amount																									$ 50,000

Note 4 - Revenue Recognition (D

Note 4 - Revenue Recognition (Details Textual) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Contract with Customer, Liability, Total	$ 10,954,000	$ 3,569,000
Commercial Coffee Segment [Member]
Contract with Customer, Liability, Total	4,305,000	0
Commercial Hemp Segment [Member]
Contract with Customer, Liability, Total	627,000	0
Customer Deposits [Member]
Contract with Customer, Liability, Total	1,800,000	1,626,000
Rewards Program [Member]
Contract with Customer, Liability, Total	2,624,000
Heritage Makers [Member]
Contract with Customer, Liability, Total	1,598,000	1,795,000
Convention and Distributor Events [Member]
Contract with Customer, Liability, Total	$ 0	$ 148,000

Note 4 - Revenue Recognition -

Note 4 - Revenue Recognition - Disaggregated Revenue by Segment (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Revenue	$ 34,002	$ 33,380	$ 102,525	$ 112,789
Direct Selling Segment [Member]
Revenue	31,319	30,256	92,750	95,800
Commercial Coffee Segment [Member]
Revenue	2,482	2,940	8,775	16,464
Commercial Coffee Segment [Member] | Processed Green Coffee [Member]
Revenue	254	(22)	773	1,046
Commercial Coffee Segment [Member] | Milling and Processing Services [Member]
Revenue	211	29	535	6,416
Commercial Coffee Segment [Member] | Roasted Coffee and Other [Member]
Revenue	2,017	2,933	7,467	9,002
Commercial Hemp Segment [Member]
Revenue	$ 201	$ 184	$ 1,000	$ 525

Note 4 - Revenue Recognition _2

Note 4 - Revenue Recognition - Deferred Revenue Balances (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Accrued expenses	$ 627	$ 0
Deferred revenue	8,527	1,943
Other current liabilities	1,800	1,626
Deferred revenue, total	$ 10,954	$ 3,569

Note 5 - Selected Consolidate_3

Note 5 - Selected Consolidated Balance Sheet Information (Details Textual) - USD ($)	1 Months Ended	3 Months Ended		9 Months Ended		12 Months Ended
	Aug. 31, 2020	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Accounts Receivable, Credit Loss Expense (Reversal)				$ (30,000)	$ 0
Depreciation, Total		$ 635,000	$ 617,000	1,968,000	1,694,000
Finance Lease, Right-of-Use Asset, Accumulated Amortization		2,070,000		2,070,000		$ 1,367,000
Amortization of Intangible Assets		600,000	$ 1,249,000	1,840,000	$ 2,505,000
Trademarks [Member]
Indefinite-Lived Intangible Assets (Excluding Goodwill), Ending Balance		1,649,000		1,649,000		1,649,000
CBD Oil Extraction Equipment With VFI [Member]
Sale Leaseback Transaction, Net Book Value, Total	$ 2,006,000
Sale Leaseback Transaction, Monthly Payment	79,000
Sale Leaseback Transaction, Advanced Payment	$ 79,000
Land [Member]
Assets Held-for-sale, Not Part of Disposal Group, Total		1,053,000		1,053,000
Computer Equipment [Member] | Commercial Hemp Segment [Member]
Assets Held-for-sale, Not Part of Disposal Group, Total		$ 443,000		443,000
H&H Export [Member]
Accounts Receivable, after Allowance for Credit Loss, Total						8,707,000
Accounts Receivable, Credit Loss Expense (Reversal)				$ 7,871,000		$ 7,871,000

Note 5 - Selected Consolidate_4

Note 5 - Selected Consolidated Balance Sheet Information - Accounts Receivables (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Accounts receivable	$ 11,253	$ 11,142
Allowance for doubtful accounts	(8,210)	(8,240)
Accounts receivable, net	$ 3,043	$ 2,902

Note 5 - Selected Consolidate_5

Note 5 - Selected Consolidated Balance Sheet Information - Inventory (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Finished goods	$ 12,448	$ 14,890
Raw materials	13,382	11,694
Total inventory	25,830	26,584
Reserve for excess and obsolete	(3,794)	(3,878)
Inventory, net	$ 22,036	$ 22,706

Note 5 - Selected Consolidate_6

Note 5 - Selected Consolidated Balance Sheet Information - Property and Equipment (Details) - USD ($) $ in Thousands		Sep. 30, 2020	Dec. 31, 2019
Buildings		$ 38,605	$ 34,777
Accumulated depreciation		(13,416)	(11,461)
Total property and equipment, net		25,189	23,316
Building [Member]
Buildings		4,117	4,789
Leasehold Improvements [Member]
Buildings		3,148	2,948
Land [Member]
Buildings		2,544	3,307
Land Improvements [Member]
Buildings		606	606
Producing Coffee Trees [Member]
Buildings		553	553
Manufacturing Equipment [Member]
Buildings		10,464	9,568
Furniture and Other Equipment [Member]
Buildings		2,062	2,050
Computer Software [Member]
Buildings		1,442	1,420
Computer Equipment [Member]
Buildings		2,714	2,648
Vehicles [Member]
Buildings		326	326
Assets Held for Sale [Member]
Buildings	[1]	1,496	0
Construction in Progress [Member]
Buildings		$ 9,133	$ 6,562
[1]Assets held for sale at September 30, 2020 consisted of approximately $1,053,000 in land and $443,000 in computer equipment related to the commercial hemp segment. (See Note 13)

Note 5 - Selected Consolidate_7

Note 5 - Selected Consolidated Balance Sheet Information - Operating and Financing Leases (Details) - USD ($) $ in Thousands		Sep. 30, 2020	Dec. 31, 2019
Operating lease right-of-use assets		$ 6,467	$ 8,386
Finance lease right-of-use assets (1)	[1]		1,052
Total leased assets			9,438
Operating lease liabilities, current portion		1,290	1,740
Finance lease liabilities, current portion		1,703	736
Total leased liabilities, current portion		2,993	2,476
Operating lease liabilities, net of current portion		5,497	6,646
Finance lease liabilities, net of current portion		1,081	408
Total lease liabilities		$ 9,571	$ 9,530
Operating leases (Year)		6 years 8 months 12 days	6 years 9 months 18 days
Finance leases (Year)		1 year 8 months 12 days	1 year 7 months 6 days
Operating leases		5.41%	5.47%
Finance leases		17.63%	4.57%
[1]Finance lease right-of-use assets are recorded within property and equipment, net of accumulated amortization of approximately $926,000 and $788,000 at September 30, 2020 and December 31, 2019, respectively.

Note 5 - Selected Consolidate_8

Note 5 - Selected Consolidated Balance Sheet Information - Operating and Finance Lease Costs (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Total operating and finance lease cost		$ 824	$ 534	$ 2,360	$ 1,337
Sales, Marketing, General and Administrative [Member]
Operating lease cost (1)	[1]	495	420	1,591	962
Depreciation and Amortization [Member]
Amortization of leased assets (2)	[2]	311	84	703	274
Interest Expense [Member]
Interest on lease liabilities (3)	[3]	$ 18	$ 30	$ 66	$ 101
[1]Operating lease costs are classified within selling and marketing and general and administrative expenses.[2]Amortization of leased assets are classified as a component of depreciation and amortization.[3]Interest on lease liabilities are classified within interest expense, net.

Note 5 - Selected Consolidate_9

Note 5 - Selected Consolidated Balance Sheet Information - Intangible Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Finite-Lived Intangible Assets, Gross	$ 35,604	$ 35,604
Finite-Lived Intangible Assets, Accumulated Amortization	21,878	20,038
Finite-Lived Intangible Assets, Net	13,726	15,566
Distributor Organization [Member]
Finite-Lived Intangible Assets, Gross	15,735	15,735
Finite-Lived Intangible Assets, Accumulated Amortization	11,090	10,418
Finite-Lived Intangible Assets, Net	4,645	5,317
Trademarks and Trade Names [Member]
Finite-Lived Intangible Assets, Gross	8,430	8,430
Finite-Lived Intangible Assets, Accumulated Amortization	3,070	2,539
Finite-Lived Intangible Assets, Net	5,360	5,891
Customer Relationships [Member]
Finite-Lived Intangible Assets, Gross	10,442	10,442
Finite-Lived Intangible Assets, Accumulated Amortization	6,934	6,413
Finite-Lived Intangible Assets, Net	3,508	4,029
Internally Developed Software [Member]
Finite-Lived Intangible Assets, Gross	720	720
Finite-Lived Intangible Assets, Accumulated Amortization	720	657
Finite-Lived Intangible Assets, Net	0	63
Noncompete Agreements [Member]
Finite-Lived Intangible Assets, Gross	277	277
Finite-Lived Intangible Assets, Accumulated Amortization	64	11
Finite-Lived Intangible Assets, Net	$ 213	$ 266

Note 5 - Selected Consolidat_10

Note 5 - Selected Consolidated Balance Sheet Information - Goodwill (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Goodwill	$ 6,992	$ 6,992
Direct Selling Segment [Member]
Goodwill	3,678	3,678
Commercial Coffee Segment [Member]
Goodwill	3,314	3,314
Commercial Hemp Segment [Member]
Goodwill	$ 0	$ 0

Note 6 - Notes Payable and Ot_2

Note 6 - Notes Payable and Other Debt (Details Textual)	1 Months Ended									3 Months Ended		4 Months Ended	9 Months Ended		12 Months Ended		13 Months Ended
	Jun. 30, 2021 USD ($)	Apr. 30, 2021 USD ($) shares	Feb. 28, 2021 USD ($) $ / shares shares	Nov. 30, 2020 USD ($)	Apr. 30, 2020 USD ($)	Mar. 31, 2020 USD ($) shares	Mar. 31, 2019 USD ($) $ / shares shares	Feb. 28, 2019 USD ($) a	Mar. 31, 2007 USD ($)	Sep. 30, 2020 USD ($) shares	Sep. 30, 2019 USD ($)	Jul. 31, 2020 USD ($)	Sep. 30, 2020 USD ($) shares	Sep. 30, 2019 USD ($)	Dec. 31, 2019 USD ($) shares	Dec. 31, 2013 USD ($)	Jul. 31, 2021 USD ($)	Jun. 17, 2022 USD ($)	Jan. 31, 2022 USD ($)	Dec. 31, 2018 USD ($) $ / shares shares
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares										5,266,187			5,266,187		6,238,182
Payments to Acquire Productive Assets, Total										$ 1,561,000	$ 1,902,000		$ 3,942,000	$ 6,879,000
Proceeds from Paycheck Protection Program Under CARES Act					$ 3,763,000								$ 142,000
Line of Credit [Member] | Crestmark Bank [Member]
Debt Instrument, Interest Rate, Effective Percentage										6.75%			6.75%		7.25%
Line of Credit Facility, Maximum Borrowing Capacity										$ 6,250,000			$ 6,250,000
Line of Credit Facility, Maximum Borrowing Capacity, Tranche One, Percentage of Value of Eligible Accounts										85%			85%
Line of Credit Facility, Maximum Borrowing Capacity, Tranche Two, Maximum Account Standard Amount										$ 1,000,000			$ 1,000,000
Line of Credit Facility, Maximum Borrowing Capacity, Tranche Two, Percentage of Eligible Inventory										50%			50%
Line of Credit Facility, Maximum Borrowing Capacity, Tranche Two, Percentage of 85% of Eligible Accounts Calculated										50%			50%
Line of Credit Facility, Maximum Borrowing Capacity, Tranche Three, Maxiumum Standard Amount Allowed										$ 250,000			$ 250,000
Line of Credit Facility, Maximum Borrowing Capacity, Tranche Three, Percentage of Specific Inventory Identified										75%			75%
Debt Instrument, Floor Rate													6.75%
Debt Instrument, Minimum Loan Balance Required Without Other Fees Occured										$ 2,000,000			$ 2,000,000
Long-Term Line of Credit, Total										1,955,000			1,955,000		$ 2,011,000
Commercial Coffee Segment [Member]
Payments to Acquire Productive Assets, Total										1,516,000	181,000		2,977,000	3,596,000
Proceeds from Paycheck Protection Program Under CARES Act					783,000												$ 150,000
Direct Selling Segment [Member]
Payments to Acquire Productive Assets, Total										15,000	594,000		266,000	674,000
Proceeds from Paycheck Protection Program Under CARES Act					2,508,000
Commercial Hemp Segment [Member]
Payments to Acquire Productive Assets, Total										30,000	1,127,000		699,000	2,609,000
Proceeds from Paycheck Protection Program Under CARES Act					$ 623,000
Extinguishment of Debt, Amount												$ 613,000
M2C Purchase Agreement [Member]
Long-Term Debt, Total										997,000			$ 997,000		1,027,000
Asset Acquisition, Consideration Transferred, Total									$ 4,500,000
Payments to Acquire Productive Assets, Total									$ 500,000
Asset Acquisition, Number of Installments for Cash Payment									3
Asset Acquisition, Monthly Payment, Percentage of Sales Related to Acquired Assets									10%
Land in Groveland, Florida [Member]
Area of Land (Acre) | a								45
Asset Held-for-use, Purchase Price								$ 750,000
Payments to Acquire Land Held-for-use								300,000
Prime Rate [Member] | Line of Credit [Member] | Crestmark Bank [Member]
Debt Instrument, Basis Spread on Variable Rate													2.50%
Forecast [Member]
Extinguishment of Debt, Amount	$ 3,141,000
Forecast [Member] | Line of Credit [Member] | Crestmark Bank [Member]
Line of Credit Facility, Maximum Borrowing Capacity																			$ 3,000,000
Line of Credit Facility, Maximum Borrowing Capacity, Tranche One, Percentage of Value of Eligible Accounts																			85%
Line of Credit Facility, Maximum Borrowing Capacity, Tranche Two, Maximum Account Standard Amount																			$ 1,000,000
Line of Credit Facility, Maximum Borrowing Capacity, Tranche Two, Percentage of Eligible Inventory																			50%
Line of Credit Facility, Maximum Borrowing Capacity, Tranche Two, Percentage of 85% of Eligible Accounts Calculated																			50%
Long-Term Line of Credit, Total																		$ 1,718,000
Forecast [Member] | Commercial Coffee Segment [Member]
Proceeds from Paycheck Protection Program Under CARES Act		$ 633,000
Extinguishment of Debt, Amount	633,000
Forecast [Member] | Direct Selling Segment [Member]
Extinguishment of Debt, Amount	$ 2,508,000
Forecast [Member] | Commercial Hemp Segment [Member]
Extinguishment of Debt, Amount				$ 613,000
Shares in Connection With Promissory Notes 2019 [Member]
Stock Issued During Period, Shares, New Issues (in shares) | shares							40,000
Shares in Connection With Promissory Notes 2019 [Member] | Forecast [Member]
Stock Issued During Period, Shares, New Issues (in shares) | shares			400,000
Stock in Connection With Mangless Note [Member]
Stock Issued During Period, Shares, New Issues (in shares) | shares						50,000
Stock in Connection With Mangless Note [Member] | Forecast [Member]
Stock Issued During Period, Shares, New Issues (in shares) | shares		1,000,000
Warrant With Credit Notes One [Member]
Warrants and Rights Outstanding, Term (Year)																				4 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares																				250,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares																				$ 6.82
Warrants With Credit Notes Two [Member]
Warrants and Rights Outstanding, Term (Year)																				4 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares																				250,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares																				$ 7.82
Credit Notes Warrants With Advisory Agreement [Member]
Warrants and Rights Outstanding, Term (Year)																				4 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares																				50,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares																				$ 6.33
Warrants in Connection With Promissory Notes 2019 [Member]
Warrants and Rights Outstanding, Term (Year)							5 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares							40,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares							$ 6
Warrants in Connection With Promissory Notes 2019 [Member] | Forecast [Member]
Warrants and Rights Outstanding, Term (Year)			2 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares			150,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares			$ 1
Credit Note [Member]
Debt Instrument, Fee Amount, Percent																				3%
Debt Instrument, Unamortized Discount, Total																				$ 1,469,000
Debt Issuance Costs, Net, Total																				175,000
Amortization of Debt Discount (Premium)										245,000	182,000		$ 678,000	503,000
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net, Total										237,000			237,000		915,000
Credit Note [Member] | CLR [Member]
Debt Instrument, Face Amount																				$ 5,000,000
Long-Term Debt, Gross										$ 5,000,000			$ 5,000,000		5,000,000
Debt Instrument, Interest Rate, Stated Percentage																				8%
Debt Instrument, Interest Rate, Effective Percentage										10%			10%
Promissory Notes 2019 [Member]
Debt Instrument, Face Amount							$ 2,000,000
Debt Instrument, Interest Rate, Stated Percentage							8%
Debt Instrument, Unamortized Discount, Total							$ 139,000
Debt Issuance Costs, Net, Total							$ 212,000
Amortization of Debt Discount (Premium)										$ 47,000	$ 41,000		$ 135,000	$ 83,000
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net, Total										93,000			93,000		228,000
Debt Instrument, Term (Year)							2 years
Long-Term Debt, Total										2,000,000			2,000,000		2,000,000
Promissory Notes 2019 [Member] | Forecast [Member]
Debt Instrument, Face Amount			$ 2,000,000
Debt Instrument, Interest Rate, Stated Percentage			16%
Mangless Note [Member]
Debt Instrument, Face Amount						$ 1,000,000
Debt Instrument, Interest Rate, Stated Percentage						18%
Debt Instrument, Unamortized Discount, Total						$ 65,000				31,000			31,000
Amortization of Debt Discount (Premium)										16,000			34,000
Boswell Mortgage Note 2400 [Member]
Debt Instrument, Face Amount																$ 3,625,000
Debt Instrument, Term (Year)																25 years
Long-Term Debt, Total										3,082,000			$ 3,082,000		$ 3,143,000
Debt Instrument, Interest Rate During Period													5.75%		7.50%
Boswell Mortgage Note 2400 [Member] | Prime Rate [Member]
Debt Instrument, Basis Spread on Variable Rate																2.50%
Khrysos Mortgage Notes for Properties in Clemont, Florida [Member]
Debt Instrument, Face Amount						$ 350,000
Debt Instrument, Interest Rate, Stated Percentage						8%
Khrysos Mortgage Notes for Properties in Mascotte, Florida [Member]
Debt Instrument, Face Amount						$ 177,000
Debt Instrument, Interest Rate, Stated Percentage						7%
Long-Term Debt, Total										517,000			$ 517,000		$ 528,000
Mortgage With Land Acquisition in Groveland, Florida [Member]
Debt Instrument, Face Amount								$ 450,000
Debt Instrument, Interest Rate, Stated Percentage								6%
Long-Term Debt, Total										432,000			432,000		440,000
Mortgage Debt [Member]
Repayments of Debt										70,000
Other Notes Related to Loans for Commercial Vans [Member]
Long-Term Debt, Total										$ 56,000			$ 56,000		$ 71,000

Note 7 - Convertible Notes Pa_3

Note 7 - Convertible Notes Payable (Details Textual) - USD ($)	3 Months Ended	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2020	Sep. 30, 2019	Mar. 31, 2021	Feb. 28, 2021	Dec. 31, 2019	Jul. 31, 2019
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)		5,266,187				6,238,182
Warrants With 2014 Private Placement [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)	929,346
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)	$ 4.60
PIPE Notes 2019 Converted into Common Stock [Member]
Debt Instrument, Convertible, Conversion Price (in dollars per share)							$ 10
PIPE 2014 Debt Converted into Common Stock [Member]
Debt Instrument, Convertible, Conversion Price (in dollars per share)	$ 7
Debt Conversion, Converted Instrument, Shares Issued (in shares)	678,568
The 2019 Private Placement Debt Offering [Member]
Number of Shares Received for Every $100,000 Invested (in shares)							2,000
The 2019 Private Placement Debt Offering [Member]
Debt Instrument, Face Amount							$ 10,000,000
Debt Instrument, Unamortized Discount, Total							451,000
Subscription Agreement [Member]
Debt Instrument, Face Amount							$ 3,090,000
PIPE Notes 2019 [Member]
Debt Instrument, Face Amount		$ 3,090,000				$ 3,090,000
Debt Instrument, Interest Rate, Stated Percentage		6%				6%	6%
Debt Instrument, Unamortized Discount, Total		$ 163,000				$ 415,000	$ 671,000
Amortization of Debt Discount (Premium)		252,000	$ 172,000
PIPE Notes 2019 [Member] | Forecast [Member]
Debt Instrument, Face Amount				$ 1,440,000	$ 1,000,000
Debt Instrument, Interest Rate, Stated Percentage				12%	16%
PIPE Notes 2019 Amendment [Member] | Forecast [Member]
Debt Instrument, Face Amount				$ 2,440,000
PIPE Notes 2014 [Member]
Debt Instrument, Face Amount	$ 4,750,000	$ 0				$ 25,000
Debt Instrument, Interest Rate, Stated Percentage	8%	8%	8%			8%
Debt Instrument, Unamortized Discount, Total		$ 0				$ 0
Amortization of Debt Discount (Premium)			$ 94,000
Proceeds from Issuance of Long-Term Debt, Total	$ 4,750,000
Debt Instrument, Term (Year)	5 years
Long-Term Debt, Total			25,000
Debt Instrument, Debt Discount Related to Beneficial Conversion Feature	$ 4,750,000
Debt Instrument, Debt Discount Related to Debt Exchange	679,000
Payment of Financing and Stock Issuance Costs, Total	490,000
Debt Issuance Costs Related to Debt Exchange	$ 63,000
Amortization of Debt Issuance Costs			$ 10,000

Note 7 - Convertible Notes Pa_4

Note 7 - Convertible Notes Payable - Convertible Notes Payable (Details) - USD ($)	Sep. 30, 2020	Dec. 31, 2019	Jul. 31, 2019	Sep. 30, 2014
Carrying value Notes	$ 2,927,000	$ 2,700,000
PIPE Notes 2019 [Member]
Convertible Notes, principal	3,090,000	3,090,000
Debt discounts	(163,000)	(415,000)	$ (671,000)
Carrying value Notes	2,927,000	2,675,000
PIPE Notes 2014 [Member]
Convertible Notes, principal	0	25,000		$ 4,750,000
Debt discounts	0	0
Carrying value Notes	$ 0	$ 25,000

Note 7 - Convertible Notes Pa_5

Note 7 - Convertible Notes Payable - Convertible Notes Payable (Details) (Parentheticals)	Sep. 30, 2020	Dec. 31, 2019	Sep. 30, 2019	Jul. 31, 2019	Sep. 30, 2014
PIPE Notes 2019 [Member]
Debt Instrument, Interest Rate	6%	6%		6%
PIPE Notes 2014 [Member]
Debt Instrument, Interest Rate	8%	8%	8%		8%

Note 8 - Derivative Liability_2

Note 8 - Derivative Liability (Details Textual) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Derivative Liability, Total	$ 6,796,000		$ 6,796,000		$ 10,153,000
Derivative, Loss on Derivative	101,000	$ 2,457,000	1,542,000	$ 4,344,000
Warrants [Member]
Derivative Liability, Total	$ 0		$ 0		$ 1,542,000

Note 8 - Derivative Liability -

Note 8 - Derivative Liability - Estimated Fair Value Assumption of Warrant Derivative (Details) - Warrants [Member]	Dec. 31, 2019
Measurement Input, Price Volatility [Member]
Derivative Liability, Measurement Input	0.6410
Measurement Input, Risk Free Interest Rate [Member] | Minimum [Member]
Derivative Liability, Measurement Input	1.59
Measurement Input, Risk Free Interest Rate [Member] | Maximum [Member]
Derivative Liability, Measurement Input	0.0160
Measurement Input, Expected Dividend Rate [Member]
Derivative Liability, Measurement Input	0
Measurement Input, Expected Term [Member] | Minimum [Member]
Derivative Liability, Measurement Input	0.6
Measurement Input, Expected Term [Member] | Maximum [Member]
Derivative Liability, Measurement Input	1

Note 9 - Fair Value of Financ_3

Note 9 - Fair Value of Financial Instruments (Details Textual)	Sep. 30, 2020	Dec. 31, 2019
Measurement Input, Discount Rate [Member]
Business Combination, Contingent Consideration, Liability, Measurement Input	18.50	18.42

Note 9 - Fair Value of Financ_4

Note 9 - Fair Value of Financial Instruments - Fair Value Measurement (Details) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Contingent acquisition debt, current portion	$ 1,341,000	$ 1,263,000
Contingent acquisition debt, net of current portion	5,455,000	7,348,000
Total derivative liabilities	6,796,000	10,153,000
Warrants [Member]
Total derivative liabilities	0	1,542,000
Fair Value, Inputs, Level 1 [Member]
Contingent acquisition debt, current portion	0	0
Contingent acquisition debt, net of current portion	0	0
Total derivative liabilities	0	0
Fair Value, Inputs, Level 1 [Member] | Warrants [Member]
Total derivative liabilities	0	0
Fair Value, Inputs, Level 2 [Member]
Contingent acquisition debt, current portion	0	0
Contingent acquisition debt, net of current portion	0	0
Total derivative liabilities	0	0
Fair Value, Inputs, Level 2 [Member] | Warrants [Member]
Total derivative liabilities	0	0
Fair Value, Inputs, Level 3 [Member]
Contingent acquisition debt, current portion	1,341,000	1,263,000
Contingent acquisition debt, net of current portion	5,455,000	7,348,000
Total derivative liabilities	6,796,000	10,153,000
Fair Value, Inputs, Level 3 [Member] | Warrants [Member]
Total derivative liabilities	$ 0	$ 1,542,000

Note 9 - Fair Value of Financ_5

Note 9 - Fair Value of Financial Instruments - Derivative Liabilities (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Balance at December 31, 2019			$ 10,153,000
Adjustments to estimated fair value	$ 0	$ (27,000)	0	$ (1,529,000)
Balance at September 30, 2020 (unaudited)	6,796,000		6,796,000
Warrants [Member]
Balance at December 31, 2019			1,542,000
Balance at September 30, 2020 (unaudited)	0		0
Fair Value, Inputs, Level 3 [Member]
Balance at December 31, 2019			10,153,000
Balance at September 30, 2020 (unaudited)	6,796,000		6,796,000
Fair Value, Inputs, Level 3 [Member] | Warrants [Member]
Balance at December 31, 2019			1,542,000
Adjustments to estimated fair value			(1,542,000)
Balance at September 30, 2020 (unaudited)	$ 0		$ 0

Note 9 - Fair Value of Financ_6

Note 9 - Fair Value of Financial Instruments - Contingent Liabilities Measured at Fair Value (Details) - Fair Value, Inputs, Level 3 [Member] - Contingent Liabilities [Member] $ in Thousands	9 Months Ended
	Sep. 30, 2020 USD ($)
Balance at December 31, 2019	$ 8,611
Liabilities settled	(175)
Adjustments to liabilities included in earnings	(1,640)
Balance at September 30, 2020 (unaudited)	$ 6,796

Note 10 - Stockholders' Equit_2

Note 10 - Stockholders' Equity (Details Textual)	1 Months Ended																		2 Months Ended	3 Months Ended					4 Months Ended	6 Months Ended			9 Months Ended		12 Months Ended			13 Months Ended	19 Months Ended	24 Months Ended	29 Months Ended
	Aug. 31, 2021 shares	Apr. 30, 2021 shares	Feb. 28, 2021 USD ($) $ / shares shares	Aug. 31, 2020 shares	Mar. 31, 2020 USD ($) $ / shares shares	Jan. 31, 2020 USD ($) $ / shares shares	Aug. 31, 2019 USD ($) $ / shares shares	Jul. 31, 2019 USD ($) $ / shares shares	Jun. 30, 2019 USD ($) $ / shares shares	Apr. 30, 2019 USD ($) shares	Mar. 31, 2019 USD ($) $ / shares shares	Feb. 28, 2019 USD ($) $ / shares shares	Jan. 31, 2019 USD ($) $ / shares shares	Oct. 31, 2018 USD ($) $ / shares shares	Jul. 31, 2018 USD ($) shares	Apr. 30, 2018 USD ($) shares	Mar. 31, 2018 USD ($) $ / shares shares	Aug. 31, 2017 $ / shares shares	Mar. 31, 2021 USD ($) shares	Dec. 31, 2020 USD ($) $ / shares shares	Sep. 30, 2020 USD ($) $ / shares shares	Mar. 31, 2020 USD ($) $ / shares shares	Sep. 30, 2019 USD ($)	Oct. 31, 2018 USD ($) $ / shares shares	Dec. 31, 2019 USD ($) $ / shares shares	Jun. 15, 2022 USD ($) $ / shares	Dec. 31, 2020 $ / shares shares	Jul. 31, 2019 USD ($) $ / shares shares	Sep. 30, 2020 USD ($) $ / shares shares	Sep. 30, 2019 USD ($) $ / shares	Dec. 31, 2021 USD ($)	Dec. 31, 2019 USD ($) $ / shares shares	Dec. 31, 2018 $ / shares shares	Sep. 30, 2020 USD ($) $ / shares shares	Sep. 30, 2020 USD ($) $ / shares shares	Dec. 31, 2021 $ / shares	Sep. 30, 2020 USD ($) $ / shares shares	Jan. 31, 2021	Jan. 01, 2019 USD ($)	May 31, 2018 USD ($)	Sep. 30, 2014 $ / shares shares
Common Stock, Shares Authorized (in shares)																					50,000,000				50,000,000				50,000,000			50,000,000		50,000,000	50,000,000		50,000,000
Common Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares																					$ 0.001				$ 0.001				$ 0.001			$ 0.001		$ 0.001	$ 0.001		$ 0.001
Preferred Stock, Shares Authorized (in shares)																					5,000,000				5,000,000				5,000,000			5,000,000		5,000,000	5,000,000		5,000,000
Preferred Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares																					$ 0.001				$ 0.001				$ 0.001			$ 0.001		$ 0.001	$ 0.001		$ 0.001
Sale of Stock, Maximum Sale Amount Allowed | $																																								$ 75,000,000
Sale of Stock, Minimum Market Value of Voting Securities Held by Non-affiliates | $																																								$ 75,000,000
Proceeds from Issuance of Preferred Stock and Preference Stock | $																													$ 233,000	$ 7,323,000
Common Stock, Shares, Outstanding, Ending Balance (in shares)																					32,236,994				30,274,601				32,236,994			30,274,601		32,236,994	32,236,994		32,236,994
Number of Vote Each Shareholder Owns																					1								1					1	1		1
Proceeds from Issuance of Common Stock | $																													$ 0	102,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)																					5,266,187				6,238,182				5,266,187			6,238,182		5,266,187	5,266,187		5,266,187
Payments of Commissions | $																																			$ 0
Stock Issued During Period, Value, New Issues | $																							$ 7,323,000
Class of Warrant or Right, Outstanding (in shares)																					5,266,187				6,238,182				5,266,187			6,238,182		5,266,187	5,266,187		5,266,187
Dividends Payable | $																					$ 120,000		83,000						$ 120,000	83,000				$ 120,000	$ 120,000		$ 120,000
Class of Warrant or Right, Issued During Period (in shares)																													250,000
Payments of Dividends, Total | $																													$ 1,108,000	46,000
Stock Issued During Period, Value, Issued for Services | $																							478,000							1,466,000
Class of Warrant or Right, Exercisable, Outstanding (in shares)																					5,208,374								5,208,374					5,208,374	5,208,374		5,208,374
Class of Warrant or Right, Weighted Average Remaining Contractual Term (Year)																													1 year 6 months
Class of Warrant or Right, Outstanding, Intrinsic Value | $																					$ 0				$ 95,000				$ 0			$ 95,000		$ 0	$ 0		$ 0
Gain (Loss) on Modification of Warrants | $																					0		$ (876,000)						$ 0	$ (876,000)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares																														$ 4.18
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)																													0
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | $																					746,000								$ 746,000					746,000	746,000		746,000
Share Price (in dollars per share) | $ / shares							$ 4.55											$ 4.53															$ 5.72
Share-Based Payment Arrangement, Option [Member]
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)																													1 year 2 months 12 days
Restricted Stock Units (RSUs) [Member]
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures, Total (in shares)				39,750																									12,501			5,556
Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation (in shares)				9,632
Restricted Stock Units (RSUs) [Member] | Consultants [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted (in shares)							50,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)							3 years
Restricted Stock Units (RSUs) [Member] | Employee and Consultant [Member]
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)																													2 years 10 months 24 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted (in shares)																		500,000
Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount | $																					$ 1,028,000								$ 1,028,000					$ 1,028,000	$ 1,028,000		$ 1,028,000
Restricted Stock Units (RSUs) [Member] | Employee and Consultant [Member] | Share-Based Payment Arrangement, Tranche One [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage																		10%
Restricted Stock Units (RSUs) [Member] | Employee and Consultant [Member] | Share-Based Payment Arrangement, Tranche Two [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage																		15%
Restricted Stock Units (RSUs) [Member] | Employee and Consultant [Member] | Share-Based Payment Arrangement, Tranche Three [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage																		50%
Restricted Stock Units (RSUs) [Member] | Employee and Consultant [Member] | Share-Based Payment Arrangement, Tranche Four [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage																		25%
Mr. Daniel Mangless [Member]
Debt Instrument, Face Amount | $					$ 1,000,000																	$ 1,000,000
Stock Issued During Period, Shares, New Issues (in shares)					50,000				250,000			250,000
Shares Issued, Price Per Share (in dollars per share) | $ / shares									$ 5.50			$ 7
Warrants and Rights Outstanding, Term (Year)												3 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)												250,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares												$ 7
Proceeds from Issuance or Sale of Equity, Total | $									$ 1,375,000			$ 1,750,000
Ivan Gandrud Chevrolet, Inc [Member] | Mr. Daniel Mangless [Member]
Ownership Percentage																					100%								100%					100%	100%		100%
Capital Market Solutions, LLC [Member]
Warrants and Rights Outstanding, Term (Year)													4 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)													925,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares													$ 6
Stock Issued During Period, Shares, Issued for Services (in shares)													75,000		100,000														100,000
Base Fee | $													$ 525,000		$ 300,000															$ 100,000
Payment of Base Fee for Services | $															50,000														$ 125,000
Base Fee, Monthly Payment | $															$ 25,000
Stock Issued During Period, Value, Issued for Services | $																													1,226,000
Class of Warrant or Right, Vesting Rights, Percentage						25%							50%
Amortization of Stock Issuance Costs | $																													386,000	386,000
Amortization of Equity Issuance Expense Related to Vested Warrants | $																													280,000	2,197,000
Corinthian Partners, LLC [Member]
Stock Issued During Period, Shares, New Issues (in shares)							600
Stock Issued During Period, Value, New Issues | $							$ 3,000
Stock Issued, Percentage of Shares Issued in Total							10%
Greentree Financial Group, Inc [Member]
Stock Issued During Period, Shares, Issued for Services (in shares)																	75,000
Stock Issued During Period, Value, Issued for Services | $																	$ 311,000
Amortization of Stock Issuance Costs | $																														134,000
I-Bankers [member]
Stock Issued During Period, Shares, Issued for Services (in shares)										100,000
Stock Issued During Period, Value, Issued for Services | $										$ 571,000
Amortization of Stock Issuance Costs | $																													143,000	286,000
Ignition [Member]
Warrants and Rights Outstanding, Term (Year)											3 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)											100,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares											$ 10
Warrants and Rights Outstanding | $											$ 414,000
Stock Issued During Period, Value, New Issues | $											$ 384,000
Stock Issued During Period, Shares, Issued for Services (in shares)											55,000					50,000
Stock Issued During Period, Value, Issued for Services | $																$ 208,000
Amortization of Stock Issuance Costs | $																														89,000
Stock Issued During Period, Shares, Equity Transactions (in shares)											5,000
Ivan Gandrud Chevrolet, Inc [Member]
Warrants and Rights Outstanding, Term (Year)					5 years																	5 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)					250,000																	250,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares					$ 4.75																	$ 4.75
Warrants and Rights Outstanding | $					$ 167,000																	$ 167,000
Stock Issued During Period, Shares, Issued for Services (in shares)					125,000
Stock Issued During Period, Value, Issued for Services | $					$ 158,000
Amortization of Stock Issuance Costs | $																													$ 325,000
Benchmark Company [member]
Stock Issued During Period, Shares, Issued for Services (in shares)							20,000
Stock Issued During Period, Value, Issued for Services | $							$ 91,000
Minimum [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares																					$ 4.60								$ 4.60					$ 4.60	$ 4.60		$ 4.60
Maximum [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares																					$ 10								$ 10					$ 10	$ 10		$ 10
Conversion of Series B Preferred Stock into Common Stock [Member]
Conversion of Stock, Shares Converted (in shares)																						129,332										105
Conversion of Stock, Shares Issued (in shares)																						258,664										210
Conversion of 2014 Convertible Note into Common Stock [Member]
Debt Conversion, Original Debt, Amount | $														$ 4,000,000
Debt Conversion, Converted Instrument, Shares Issued (in shares)														747,664
Debt Instrument, Convertible, Conversion Price (in dollars per share) | $ / shares														$ 5.35										$ 5.35
Warrants in Connection With Securities Purchase Agreement [Member]
Warrants and Rights Outstanding, Term (Year)												3 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)												250,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares												$ 7
Purchase Agreements Warrants for Consulting Fees [Member]
Warrants and Rights Outstanding, Term (Year)												3 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)												100,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares												$ 10
Warrants and Rights Outstanding | $												$ 324,000
Warrants in Connection With Promissory Notes 2019 [Member]
Warrants and Rights Outstanding, Term (Year)											5 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)											40,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares											$ 6
Warrants and Rights Outstanding | $											$ 138,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights for Each $1,000,000 Invested (in shares)											20,000
Warrants to Debt Exchange Dealer [Member]
Class of Warrant or Right, Outstanding (in shares)																					150,000				150,000				150,000			150,000		150,000	150,000		150,000
Warrants in Connection With 2018 Private Placement [Member]
Warrants and Rights Outstanding, Term (Year)														3 years										3 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)														630,526							448,420			630,526					448,420					448,420	448,420		448,420
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares														$ 4.75										$ 4.75
Warrants and Rights Outstanding | $														$ 1,689,000										$ 1,689,000
Warrants in Connection With 2018 Private Placement [Member] | Reclassified From Derivative Liability to Equity [Member]
Warrants and Rights Outstanding | $																																							$ 1,494,000
Warrants With 2014 Convertible Note [Member]
Warrants and Rights Outstanding, Term (Year)														4 years										4 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)														631,579							631,579			631,579	631,579				631,579			631,579		631,579	631,579		631,579
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares														$ 4.75										$ 4.75
Warrants With 2014 Convertible Note [Member] | Mr. Grover [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)								782,608	782,608																			782,608
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares								$ 4.60																				$ 4.60
Stock Issued During Period, Shares, Warrants Exercised (in shares)								600,242
Proceeds from Warrant Exercises | $								$ 2,761,000
Stock Issued During Period, Shares, for Inducement Shares (in shares)								50,000
Warrants to Debt Exchange Dealer One [Member]
Warrants and Rights Outstanding, Term (Year)														4 years										4 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)														80,000										80,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares														$ 5.35										$ 5.35
Warrants to Debt Exchange Dealer Two [Member]
Warrants and Rights Outstanding, Term (Year)														4 years										4 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)														70,000										70,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares														$ 4.75										$ 4.75
Warrants With Series B Offering [Member]
Warrants and Rights Outstanding | $																	$ 75,000
Class of Warrant or Right, Outstanding (in shares)																					6,098				6,098				6,098			6,098		6,098	6,098		6,098
Class of Warrant or Right, Issued During Period (in shares)																	38,117
Class of Warrant or Right, Exercisable, Exercise Price (in dollars per share) | $ / shares																	$ 5.70
Warrants With Series C Offering [Member]
Stock Issued During Period, Shares, Warrants Exercised (in shares)																																99,143
Class of Warrant or Right, Issued During Period (in shares)																																	116,867
Class of Warrant or Right, Exercisable, Exercise Price (in dollars per share) | $ / shares																																	$ 4.75
Warrants With 2014 Private Placement [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)																																									929,346
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares																																									$ 4.60
Warrants With 2014 Private Placement [Member] | One July 2014 Investor [Member]
Stock Issued During Period, Shares, Warrants Exercised (in shares)								19,565
Stock Issued During Period, Shares, for Inducement Shares (in shares)								2,500
Warrants With 2014 Private Placement [Member] | One August 2014 Investor [Member]
Stock Issued During Period, Shares, Warrants Exercised (in shares)							48,913
Proceeds from Warrant Exercises | $							$ 228,000
Stock Issued During Period, Shares, for Inducement Shares (in shares)							5,750
Placement Agent Warrants One [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)																																									44,107
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares																																									$ 7
Placement Agent Warrants Two [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)																																									60,407
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares																																									$ 4.60
Preferred Warrants [Member] | One Investor From Series C Offering [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)							63,156
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares							$ 4.75
Stock Issued During Period, Shares, Warrants Exercised (in shares)							63,156
Proceeds from Warrant Exercises | $							$ 300,000
Stock Issued During Period, Shares, for Inducement Shares (in shares)							6,000
Forecast [Member] | Restricted Stock Units (RSUs) [Member]
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures, Total (in shares)	54,000
Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation (in shares)	12,575
Forecast [Member] | Mr. Daniel Mangless [Member]
Common Stock, Shares, Outstanding, Ending Balance (in shares)			176,000
Stock Issued During Period, Shares, New Issues (in shares)		1,000,000
Forecast [Member] | Capital Market Solutions, LLC [Member]
Class of Warrant or Right, Vesting Rights, Percentage																																						25%
Forecast [Member] | Warrants in Connection With Promissory Notes 2019 [Member]
Warrants and Rights Outstanding, Term (Year)			2 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)			150,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares			$ 1
Forecast [Member] | Warrants With 2014 Convertible Note [Member] | Mr. Grover [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)																				182,366							182,366
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares																				$ 4.75							$ 4.75
March 2020 Private Placement Debt Offering [Member]
Stock Issued During Period, Shares, New Issues (in shares)					250,000
Shares Received Per Standard Amounts Invested (in shares)					50,000																	50,000
Senior Secured Promissory Note With Securities Purchase Agreement [Member]
Stock Issued During Period, Shares, New Issues (in shares)					50,000
Senior Secured Promissory Note With Securities Purchase Agreement [Member] | Forecast [Member]
Stock Issued During Period, Shares, New Issues (in shares)		1,000,000
Securities Purchase Agreement With Daniel Mangless [Member]
Stock Issued During Period, Shares, New Issues (in shares)									250,000			250,000
Shares Issued, Price Per Share (in dollars per share) | $ / shares									$ 5.50			$ 7
Stock Issuance Fees | $									$ 0
Proceeds from Issuance of Common Stock | $									$ 1,375,000
Proceeds from Issuance or Sale of Equity, Total | $												$ 1,750,000
Purchase Agreement Shares Issued for Consulting Fees [Member]
Stock Issued During Period, Shares, New Issues (in shares)												5,000
Shares Issued, Price Per Share (in dollars per share) | $ / shares												$ 7
Shares in Connection With Promissory Notes 2019 [Member]
Stock Issued During Period, Shares, New Issues (in shares)											40,000
Number of Stocks Issued for Each $1,000,000 Invested (in shares)											20,000
Stock Issued During Period, Value, New Issues | $											$ 212,000
Shares in Connection With Promissory Notes 2019 [Member] | Forecast [Member]
Stock Issued During Period, Shares, New Issues (in shares)			400,000
The 2019 Private Placement Debt Offering [Member]
Stock Issued During Period, Shares, New Issues (in shares)																												61,800
Number of Shares Received for Every $100,000 Invested (in shares)								2,000																				2,000
Stock Issued to Placement Agent [Member]
Stock Issued During Period, Shares, New Issues (in shares)																												15,450
Stock Issued to Placement Agent [Member] | Forecast [Member]
Stock Issued During Period, Shares, New Issues (in shares)																			366,000
At-the-market Equity Offering Program [Member]
Stock Issued During Period, Shares, New Issues (in shares)													17,524
Proceeds from Issuance of Common Stock | $													$ 102,000
Maximum Shares Allowed to Sell Through Sales Agent (in shares)													60,000,000
Commissions, Percent of Gross Sales Proceeds													3%
Private Placement 2018 [Member]
Stock Issued During Period, Shares, New Issues (in shares)																								630,526
Shares Issued, Price Per Share (in dollars per share) | $ / shares														$ 4.75										$ 4.75
Stock Issued During Period, Shares, Warrants Exercised (in shares)																																182,106
Stock Issued for Advisory Fees [Member]
Stock Issued During Period, Shares, New Issues (in shares)																								150,000
Stock Issued to Debt Exchange Dealer [Member]
Stock Issued During Period, Shares, New Issues (in shares)														30,000
March 2020 Private Placement Debt Offering [Member]
Debt Instrument, Face Amount | $					$ 5,000,000																	$ 5,000,000
Senior Secured Promissory Note With Securities Purchase Agreement [Member]
Proceeds from Issuance of Long-Term Debt, Total | $					$ 1,000,000
Promissory Notes 2019 [Member]
Debt Instrument, Face Amount | $											2,000,000
Proceeds from Issuance of Long-Term Debt, Total | $											2,000,000
Debt Instrument, Unamortized Discount, Total | $											$ 139,000
Long-Term Debt, Total | $																					$ 2,000,000				$ 2,000,000				$ 2,000,000			$ 2,000,000		$ 2,000,000	$ 2,000,000		$ 2,000,000
Promissory Notes 2019 [Member] | Forecast [Member]
Debt Instrument, Face Amount | $			$ 2,000,000
The 2019 Private Placement Debt Offering [Member]
Debt Instrument, Face Amount | $								$ 10,000,000																				$ 10,000,000
Debt Instrument, Unamortized Discount, Total | $								451,000																				451,000
PIPE Notes 2019 Amendment [Member] | Forecast [Member]
Debt Instrument, Face Amount | $																			$ 2,440,000
Private Placement 2014 [Member] | One July 2014 Investor [Member]
Repayments of Notes Payable | $								100,000
Long-Term Debt, Total | $								$ 11,000																				$ 11,000
Series A Convertible Preferred Stock [Member]
Preferred Stock, Shares Authorized (in shares)																					161,135								161,135					161,135	161,135		161,135
Preferred Stock, Dividend Rate, Percentage																													8%			8%
Preferred Stock, Shares Outstanding, Ending Balance (in shares)																					161,135				161,135				161,135			161,135		161,135	161,135		161,135
Dividends Payable | $																					$ 160,000				$ 150,000				$ 160,000			$ 150,000		$ 160,000	$ 160,000		$ 160,000
Preferred Stock, Convertible, Conversion Ratio																					0.1								0.1					0.1	0.1		0.1
Series B Convertible Preferred Stock [Member]
Preferred Stock, Shares Authorized (in shares)																					1,052,631								1,052,631					1,052,631	1,052,631		1,052,631
Preferred Stock, Dividend Rate, Percentage																													5%			5%
Stock Issued During Period, Shares, New Issues (in shares)																	381,173
Shares Issued, Price Per Share (in dollars per share) | $ / shares																	$ 9.50
Preferred Stock, Shares Outstanding, Ending Balance (in shares)																					0				129,332				0			129,332		0	0		0
Dividends Payable | $																									$ 15,000							$ 15,000
Preferred Stock, Convertible, Conversion Ratio					2												2					2
Preferred Stock, Convertible, Conversion Price (in dollars per share) | $ / shares																	$ 4.75
Payments of Dividends, Total | $																													$ 32,000	$ 46,000
Series C Preferred Stock [Member]
Preferred Stock, Shares Authorized (in shares)																					700,000								700,000					700,000	700,000		700,000
Preferred Stock, Shares Outstanding, Ending Balance (in shares)																									0							0
Series D Cumulative Redeemable Perpetual Preferred Stock [Member]
Preferred Stock, Shares Authorized (in shares)																					650,000								650,000					650,000	650,000		650,000
Preferred Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares																					$ 0.001								$ 0.001					$ 0.001	$ 0.001		$ 0.001
Preferred Stock, Dividend Rate, Percentage																									9.75%				9.75%			9.75%
Proceeds from Issuance of Preferred Stock and Preference Stock | $																																		$ 12,269,000			$ 12,371,000
Stock Issued During Period, Shares, New Issues (in shares)																									578,898
Preferred Stock, Shares Outstanding, Ending Balance (in shares)																					590,273				578,898				590,273			578,898		590,273	590,273		590,273
Dividends Payable | $																					$ 120,000				$ 118,000				$ 120,000			$ 118,000		$ 120,000	$ 120,000		$ 120,000
Payments of Dividends, Total | $																													$ 1,076,000
Preferred Stock, Additional Shares Available for Issuance (in shares)																					59,727								59,727					59,727	59,727		59,727
Preferred Stock, Dividends Per Share, Declared (in dollars per share) | $ / shares																													$ 2.4375
Preferred Stock, Monthly Dividends Per Share, Declared (in dollars per share) | $ / shares																													0.203125
Preferred Stock, Liquidation Preference Per Share (in dollars per share) | $ / shares																					$ 25								25					$ 25	$ 25		$ 25
Preferred Stock, Redemption Price Per Share (in dollars per share) | $ / shares																					$ 25								$ 25					$ 25	$ 25		$ 25
Series D Cumulative Redeemable Perpetual Preferred Stock [Member] | Weighted Average [Member]
Shares Issued, Price Per Share (in dollars per share) | $ / shares																									$ 24.05							$ 24.05
Series D Cumulative Redeemable Perpetual Preferred Stock [Member] | Forecast [Member]
Preferred Stock, Dividend Rate, Percentage																											9.75%				9.75%
Payments of Dividends, Total | $																				$ 360,000						$ 719,000					$ 1,440,000
Preferred Stock, Dividends Per Share, Declared (in dollars per share) | $ / shares																										$ 0.203125	$ 0.203125									$ 0.203125
Series D Cumulative Redeemable Perpetual Preferred Stock [Member] | Over-Allotment Option [Member]
Proceeds from Issuance of Preferred Stock and Preference Stock | $						$ 259,000
Stock Issued During Period, Shares, New Issues (in shares)						11,375																			43,500
Shares Issued, Price Per Share (in dollars per share) | $ / shares						$ 22.75
Number of Overallotment Shares Avaiable for Purchase (in shares)																									36,809							36,809

Note 10 - Stockholders' Equit_3

Note 10 - Stockholders' Equity - Summary of Warrant Activity (Details)	9 Months Ended
	Sep. 30, 2020 shares
Outstanding at December 31, 2019 (in shares)	6,238,182
Class of Warrant or Right, Issued During Period (in shares)	250,000
Expired / cancelled (in shares)	(1,221,995)
Exercised (in shares)	0
Outstanding at September 30, 2020 (unaudited) (in shares)	5,266,187

Note 10 - Stockholders' Equit_4

Note 10 - Stockholders' Equity - Stock-based Compensation (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Stock-based compensation	$ 252	$ 661	$ 777	$ 12,418
Cost of Sales [Member]
Stock-based compensation	5	6	16	89
Selling and Marketing Expense [Member]
Stock-based compensation	31	33	92	563
General and Administrative Expense [Member]
Stock-based compensation	$ 216	$ 622	$ 669	$ 11,766

Note 10 - Stockholders' Equit_5

Note 10 - Stockholders' Equity - Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Outstanding, shares (in shares)	4,637,642
Outstanding, weighted average exercise price (in dollars per share)	$ 5.63
Outstanding, remaining contract life (Year)	7 years 1 month 6 days	7 years 9 months 18 days
Outstanding, intrinsic value	$ 0	$ 0
Granted, shares (in shares)	0
Granted, weighted average exercise price (in dollars per share)	$ 0
Granted, intrinsic value (in dollars per share)
Canceled / expired, shares (in shares)	(70,274)
Canceled / expired, weighted average exercise price (in dollars per share)	$ 4.88
Canceled / expired, intrinsic value (in dollars per share)
Exercised, shares (in shares)	0
Exercised, weighted average exercise price (in dollars per share)	$ 0
Exercised, intrinsic value	$ 0
Outstanding, shares (in shares)	4,567,368	4,637,642
Outstanding, weighted average exercise price (in dollars per share)	$ 5.64	$ 5.63
Exercisable, shares (in shares)	4,219,877
Exercisable, weighted average exercise price (in dollars per share)	$ 5.71
Exercisable, remaining contract life (Year)	7 years 1 month 6 days
Exercisable, intrinsic value	$ 0

Note 10 - Stockholders' Equit_6

Note 10 - Stockholders' Equity - Summary of Restricted Stock Unit Activity (Details) - Restricted Stock Units (RSUs) [Member]	9 Months Ended
	Sep. 30, 2020 shares
Balance at December 31, 2019 (in shares)	451,944
Issued (in shares)	0
Canceled (in shares)	(10,000)
Vested (in shares)	(52,251)
Balance at September 30, 2020 (unaudited) (in shares)	389,693

Note 11 - Commitments and Con_2

Note 11 - Commitments and Contingencies (Details Textual)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2020 USD ($) $ / lb	Sep. 30, 2019	Sep. 30, 2020 USD ($) $ / lb	Sep. 30, 2019 USD ($)	Dec. 31, 2019 USD ($)
Accounts Receivable, Credit Loss Expense (Reversal)			$ (30,000)	$ 0
Purchase Obligation, Total	$ 1,507,000		$ 1,507,000
Purchase Obligation, Average Monthly of Delay Allowed, Per Pound (in USD per Pound) | $ / lb	0.01		0.01
H&H Export [Member]
Accounts Receivable, after Allowance for Credit Loss, Total					$ 8,707,000
Accounts Receivable, Credit Loss Expense (Reversal)			$ 7,871,000		$ 7,871,000
Supplier Concentration Risk [Member] | Segment Purchases Benchmark [Member] | Direct Selling Segment [Member]
Number of Major Vendors	2	2	2	2
Supplier Concentration Risk [Member] | Segment Purchases Benchmark [Member] | Direct Selling Segment [Member] | Two Vendors [Member]
Concentration Risk, Percentage	48%	39%	46%	41%
Supplier Concentration Risk [Member] | Segment Purchases Benchmark [Member] | Commercial Coffee Segment [Member]
Number of Major Vendors	2	3	2	3
Supplier Concentration Risk [Member] | Segment Purchases Benchmark [Member] | Commercial Coffee Segment [Member] | Two Vendors [Member]
Concentration Risk, Percentage			55%
Supplier Concentration Risk [Member] | Segment Purchases Benchmark [Member] | Commercial Coffee Segment [Member] | Three Vendors [Member]
Concentration Risk, Percentage	62%	65%		70%
Supplier Concentration Risk [Member] | Segment Purchases Benchmark [Member] | Commercial Hemp Segment [Member]
Number of Major Vendors	2	2	2	1
Supplier Concentration Risk [Member] | Segment Purchases Benchmark [Member] | Commercial Hemp Segment [Member] | Two Vendors [Member]
Concentration Risk, Percentage	53%	50%	45%
Supplier Concentration Risk [Member] | Segment Purchases Benchmark [Member] | Commercial Hemp Segment [Member] | One Vendor [Member]
Concentration Risk, Percentage				35%
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Commercial Coffee Segment [Member]
Number of Major Customers	3	4	2	1
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Commercial Coffee Segment [Member] | Three Customers [Member]
Concentration Risk, Percentage	55%
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Commercial Coffee Segment [Member] | Two Customers [Member]
Concentration Risk, Percentage			39%
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Commercial Coffee Segment [Member] | Four Customers [Member]
Concentration Risk, Percentage		61%
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Commercial Coffee Segment [Member] | One Customer [Member]
Concentration Risk, Percentage				39%
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Commercial Hemp Segment [Member]
Number of Major Customers	2	4	1	3
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Commercial Hemp Segment [Member] | Three Customers [Member]
Concentration Risk, Percentage				58%
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Commercial Hemp Segment [Member] | Two Customers [Member]
Concentration Risk, Percentage	31%
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Commercial Hemp Segment [Member] | Four Customers [Member]
Concentration Risk, Percentage		75%
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Commercial Hemp Segment [Member] | One Customer [Member]
Concentration Risk, Percentage			22%

Note 12 - Segment and Geograp_3

Note 12 - Segment and Geographical Information (Details Textual)	3 Months Ended		9 Months Ended
	Sep. 30, 2020 USD ($)	Sep. 30, 2019	Sep. 30, 2020 USD ($)	Sep. 30, 2019	Dec. 31, 2019 USD ($)
Number of Operating Segments			3
Property, Plant and Equipment, Net, Total	$ 25,189,000		$ 25,189,000		$ 23,316,000
Non-US [Member]
Property, Plant and Equipment, Net, Total	$ 7,477,000		$ 7,477,000		$ 7,787,000
Non-US [Member] | Geographic Concentration Risk [Member] | Revenue Benchmark [Member]
Concentration Risk, Percentage	16%	16%	16%	15%

Note 12 - Segment and Geograp_4

Note 12 - Segment and Geographical Information - Selected Financial Information by Segments (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Revenues	$ 34,002,000	$ 33,380,000	$ 102,525,000	$ 112,789,000
Gross profit	19,754,000	19,738,000	59,587,000	72,267,000
Operating loss	(4,662,000)	(8,479,000)	(15,191,000)	(20,274,000)
Net loss	(5,072,000)	(7,874,000)	(15,403,000)	(20,423,000)
Capital expenditures	1,561,000	1,902,000	3,942,000	6,879,000
Property, plant and equipment		1,133,000		1,133,000
Total assets	85,558,000		85,558,000		$ 89,691,000
Direct Selling Segment [Member]
Revenues	31,319,000	30,256,000	92,750,000	95,800,000
Gross profit	20,429,000	19,749,000	61,425,000	64,744,000
Operating loss	(1,180,000)	(3,997,000)	(4,259,000)	(17,090,000)
Net loss	(1,271,000)	(4,332,000)	(4,556,000)	(18,959,000)
Capital expenditures	15,000	594,000	266,000	674,000
Total assets	38,349,000		38,349,000		43,221,000
Commercial Coffee Segment [Member]
Revenues	2,482,000	2,940,000	8,775,000	16,464,000
Gross profit	(407,000)	(163,000)	(1,187,000)	7,393,000
Operating loss	(1,249,000)	(2,336,000)	(4,652,000)	390,000
Net loss	(1,555,000)	(1,397,000)	(4,526,000)	2,142,000
Capital expenditures	1,516,000	181,000	2,977,000	3,596,000
Total assets	36,302,000		36,302,000		34,348,000
Commercial Hemp Segment [Member]
Revenues	201,000	184,000	1,000,000	525,000
Gross profit	(268,000)	152,000	(651,000)	130,000
Operating loss	(2,233,000)	(2,146,000)	(6,280,000)	(3,574,000)
Net loss	(2,246,000)	(2,145,000)	(6,321,000)	(3,606,000)
Capital expenditures	30,000	1,127,000	699,000	2,609,000
Property, plant and equipment		$ 1,133,000		$ 1,133,000
Total assets	$ 10,907,000		$ 10,907,000		$ 12,122,000

Note 12 - Segment and Geograp_5

Note 12 - Segment and Geographical Information - Revenues Attributable to Geographic Location (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Revenue	$ 34,002	$ 33,380	$ 102,525	$ 112,789
UNITED STATES
Revenue	28,522	28,004	85,814	96,421
Non-US [Member]
Revenue	$ 5,480	$ 5,376	$ 16,711	$ 16,368

Note 13 - Subsequent Events (De

Note 13 - Subsequent Events (Details Textual) - USD ($)	1 Months Ended																	3 Months Ended	4 Months Ended		6 Months Ended		9 Months Ended		12 Months Ended		13 Months Ended	24 Months Ended
	May 31, 2022	Feb. 28, 2022	Oct. 31, 2021	Sep. 30, 2021	Aug. 31, 2021	Jun. 30, 2021	May 31, 2021	Apr. 30, 2021	Mar. 31, 2021	Feb. 28, 2021	Nov. 30, 2020	Aug. 31, 2020	Apr. 30, 2020	Mar. 31, 2020	Jun. 30, 2019	Mar. 31, 2019	Feb. 28, 2019	Dec. 31, 2020	Jul. 31, 2020	Dec. 31, 2019	Jun. 15, 2022	Dec. 31, 2020	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2021	Dec. 31, 2019	Jul. 31, 2021	Dec. 31, 2021	Jun. 17, 2022	Jan. 31, 2022	May 31, 2020	Jul. 31, 2019	Jan. 31, 2019
Common Stock, Shares, Outstanding, Ending Balance (in shares)																				30,274,601			32,236,994			30,274,601
Proceeds from Paycheck Protection Program Under CARES Act													$ 3,763,000										$ 142,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)																				6,238,182			5,266,187			6,238,182
Payments of Dividends, Total																							$ 1,108,000	$ 46,000
Series D Cumulative Redeemable Perpetual Preferred Stock [Member]
Stock Issued During Period, Shares, New Issues (in shares)																				578,898
Preferred Stock, Dividends Per Share, Declared (in dollars per share)																							$ 2.4375
Preferred Stock, Dividend Rate, Percentage																				9.75%			9.75%			9.75%
Payments of Dividends, Total																							$ 1,076,000
Restricted Stock Units (RSUs) [Member]
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures, Total (in shares)												39,750											12,501			5,556
Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation (in shares)												9,632
CLR [Member]
Profit-sharing Split, Percent																																	75%
Minimum [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)																							$ 4.60
Maximum [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)																							$ 10
Warrants in Connection With Promissory Notes 2019 [Member]
Warrants and Rights Outstanding, Term (Year)																5 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)																40,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)																$ 6
PIPE Notes 2019 [Member]
Debt Instrument, Face Amount																				$ 3,090,000			$ 3,090,000			$ 3,090,000
Debt Instrument, Interest Rate, Stated Percentage																				6%			6%			6%						6%
Promissory Notes 2019 [Member]
Debt Instrument, Face Amount																$ 2,000,000
Debt Instrument, Interest Rate, Stated Percentage																8%
Lending Agreement [Member]
Debt Instrument, Face Amount																															$ 240,000
Debt Instrument, Interest Rate, Effective Percentage																															31%
Commercial Hemp Segment [Member]
Extinguishment of Debt, Amount																			$ 613,000
Debt Instrument, Debt, Unforgiven Amount																			$ 10,000
Proceeds from Paycheck Protection Program Under CARES Act													623,000
Commercial Coffee Segment [Member]
Proceeds from Paycheck Protection Program Under CARES Act													783,000														$ 150,000
Direct Selling Segment [Member]
Proceeds from Paycheck Protection Program Under CARES Act													$ 2,508,000
Shares in Connection With Promissory Notes 2019 [Member]
Stock Issued During Period, Shares, New Issues (in shares)																40,000
Mr. Daniel Mangless [Member]
Stock Issued During Period, Shares, New Issues (in shares)														50,000	250,000		250,000
Debt Instrument, Face Amount														$ 1,000,000
Warrants and Rights Outstanding, Term (Year)																	3 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)																	250,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)																	$ 7
Forecast [Member]
Extinguishment of Debt, Amount						$ 3,141,000
Debt Instrument, Mortgage Relief Amount Qualified										$ 18,000
Forecast [Member] | Series D Cumulative Redeemable Perpetual Preferred Stock [Member]
Preferred Stock, Dividends Per Share, Declared (in dollars per share)																					$ 0.203125	$ 0.203125						$ 0.203125
Preferred Stock, Dividend Rate, Percentage																						9.75%			9.75%
Payments of Dividends, Total																		$ 360,000			$ 719,000				$ 1,440,000
Forecast [Member] | Restricted Stock Units (RSUs) [Member]
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures, Total (in shares)					54,000
Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation (in shares)					12,575
Forecast [Member] | Groveland Property [Member]
Proceeds from Sale of Productive Assets, Total							$ 800,000
Forecast [Member] | Mascotte Facility [Member]
Proceeds from Sale of Productive Assets, Total			$ 975,000
Forecast [Member] | Clermont Property [Member]
Proceeds from Sale of Productive Assets, Total		$ 375,000
Forecast [Member] | Warrants in Connection With Promissory Notes 2019 [Member]
Warrants and Rights Outstanding, Term (Year)										2 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)										150,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)										$ 1
Forecast [Member] | PIPE Notes 2019 [Member]
Debt Instrument, Face Amount									$ 1,440,000	$ 1,000,000
Debt Instrument, Interest Rate, Stated Percentage									12%	16%
Forecast [Member] | Promissory Notes 2019 [Member]
Debt Instrument, Face Amount										$ 2,000,000
Debt Instrument, Interest Rate, Stated Percentage										16%
Forecast [Member] | Lending Agreement [Member]
Debt Instrument, Face Amount	$ 2,000,000			$ 1,965,000														$ 2,075,000				$ 2,075,000
Debt Instrument, Interest Rate, Effective Percentage	18.15%			23.17%
Proceeds from Issuance of Debt	$ 1,595,000			$ 465,000
Forecast [Member] | Lending Agreement [Member] | Minimum [Member]
Debt Instrument, Interest Rate, Stated Percentage																		20%				20%
Forecast [Member] | Lending Agreement [Member] | Maximum [Member]
Debt Instrument, Interest Rate, Stated Percentage																		25%				25%
Forecast [Member] | Commercial Hemp Segment [Member]
Extinguishment of Debt, Amount											$ 613,000
Forecast [Member] | Commercial Coffee Segment [Member]
Extinguishment of Debt, Amount						633,000
Proceeds from Paycheck Protection Program Under CARES Act								$ 633,000
Forecast [Member] | Direct Selling Segment [Member]
Extinguishment of Debt, Amount						$ 2,508,000
Forecast [Member] | Settlement Shares [Member]
Stock Issued During Period, Shares, New Issues (in shares)								1,000,000
Forecast [Member] | Stock in Connection With 2019 PIPE Notes [Member]
Stock Issued During Period, Shares, New Issues (in shares)									216,000	150,000
Forecast [Member] | Shares in Connection With Promissory Notes 2019 [Member]
Stock Issued During Period, Shares, New Issues (in shares)										400,000
Forecast [Member] | All Claims Related to Lawsuit Filed by Mr. Mangless [Member]
Litigation Settlement, Amount Awarded to Other Party								$ 195,000
Litigation Settlement, Monthly Payment to Other Party								$ 102,000
Forecast [Member] | Mr. Daniel Mangless [Member]
Common Stock, Shares, Outstanding, Ending Balance (in shares)										176,000
Stock Issued During Period, Shares, New Issues (in shares)								1,000,000
Forecast [Member] | H&H [Member] | CLR [Member]
Due from Related Parties, Total									$ 10,700,000
Notes Receivable, Related Parties									$ 5,000,000
Profit-sharing Split, Percent									25%
Offset of Payables, Related Parties									$ 243,000
Financing Receivable, Allowance for Credit Loss, Ending Balance																		$ 5,789,000				$ 5,789,000
Forecast [Member] | H&H [Member] | CLR [Member] | Trade Accounts Receivables [Member]
Accounts Receivable, Allowance for Credit Loss, Ending Balance																		$ 7,871,000				$ 7,871,000
Line of Credit [Member] | Crestmark Bank [Member]
Line of Credit Facility, Maximum Borrowing Capacity																							$ 6,250,000
Line of Credit Facility, Maximum Borrowing Capacity, Tranche One, Percentage of Value of Eligible Accounts																							85%
Line of Credit Facility, Maximum Borrowing Capacity, Tranche Two, Maximum Account Standard Amount																							$ 1,000,000
Line of Credit Facility, Maximum Borrowing Capacity, Tranche Two, Percentage of Eligible Inventory																							50%
Line of Credit Facility, Maximum Borrowing Capacity, Tranche Two, Percentage of 85% of Eligible Accounts Calculated																							50%
Long-Term Line of Credit, Total																				$ 2,011,000			$ 1,955,000			$ 2,011,000
Debt Instrument, Interest Rate, Effective Percentage																				7.25%			6.75%			7.25%
Line of Credit [Member] | Crestmark Bank [Member] | Forecast [Member]
Line of Credit Facility, Maximum Borrowing Capacity																														$ 3,000,000
Line of Credit Facility, Maximum Borrowing Capacity, Tranche One, Percentage of Value of Eligible Accounts																														85%
Line of Credit Facility, Maximum Borrowing Capacity, Tranche Two, Maximum Account Standard Amount																														$ 1,000,000
Line of Credit Facility, Maximum Borrowing Capacity, Tranche Two, Percentage of Eligible Inventory																														50%
Line of Credit Facility, Maximum Borrowing Capacity, Tranche Two, Percentage of 85% of Eligible Accounts Calculated																														50%
Long-Term Line of Credit, Total																													$ 1,718,000